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Learned associations between drug rewards and complex environmental stimuli are 
encoded in the brain and guide behavior. Studies analyzing activated neuronal 
ensembles in animal models of addiction-related behaviors, such as locomotor 
sensitization, have revealed unique molecular and celular alterations that may encode 
learning. Here, we examined activated neurons expressing the activity marker Fos in 
the nucleus accumbens after locomotor sensitization, and aimed to (I) characterize 
subtypes of neurons recruited to encode learned associations, and (I) determine if Fos-
expressing neurons encode learned associations that mediate context-specific locomotor 
sensitization. Rats were repeatedly administered amphetamine (2 mg/kg, i.p.) or saline 
(1 ml/kg i.p.) across 5-days, and after 1-week abstinence were acutely injected with 
amphetamine (0 or 1 mg/kg, i.p.) prior to a locomotor activity test. We examined co-
expression of Fos with other markers to characterize the Fos-expressing neuronal 
ensemble found in rats exhibiting locomotor sensitization. Examining Fos-expressing 
neuronal ensembles for dopamine-receptor distribution, we found increased recruitment 
of D1-receptor-expressing neurons. Examining co-expression of the Fos with ΔFosB, a 
protein marker we showed labels neurons previously activated during repeated 
administration, we found increased recruitment of ΔFosB-expressing neurons to the 
Fos-expressing neuronal ensemble. Next, we examined whether locomotor sensitization 
was context-specific by repeatedly administering amphetamine in either the testing 
context or a distinct context. Sensitized amphetamine-induced locomotor activity, Fos 
expression, and Fos/ΔFosB co-expression were induced only when rats were 
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conditioned and tested in the same context. We further established that Fos-expressing 
neurons played a causal role in context-specific locomotor sensitization by ablating 
activated neurons with the Daun02 inactivation procedure. Microinjection of Daun02 
into the accumbens shel atenuated sensitized locomotor activity when rats were 
conditioned in the same context in which they were tested, while rats conditioned in a 
diferent context from which they were tested had no change in locomotor activity, 
despite confirmed ablation of the previously activated neurons. These data highlight a 
role of activated neuronal ensembles in encoding important learned associations 
between context and drug and suggest future targets for addiction-related learned 
behaviors. 
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1.  A note about the process 
 Over the years, my expectations about what it is to have a PhD have changed 
drasticaly from the veiled, romantic imagery instiled in me at a young age. Though 
stil enamored by the prestige and immortality a PhD and published research ofers, I 
ultimately chose to get a PhD with the ambitious hope of answering some of the many 
questions posed within me about human motivation and behavior. Instead, I primarily 
learned of the literal blood, sweat, and tears that go into such a large composition, 
stealing some of the romance, but reinforcing the respect I have for those who live at 
the edge of knowledge. I have learned much about myself, the world, biology, and the 
brain, and I cherish the knowledge and skils I have accumulated the last 6-years. I 
choose to have no regrets (see Figure A, (Eatock, 2013). 
 Figure A. 
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1.  Learned associations and addiction 
 Associations made between environmental stimuli and reward shape behavior 
through conditioned learning (DeWit et al., 2015; Toregrossa and Taylor, 2016). This 
type of learning is used to meet basic needs of survival, for example, returning to 
locations with known food sources (Nairne et al., 2011). However, systems for learned 
associations can be used to reinforce mal-adaptive behavior. In the case of human 
addiction, drug-seeking and drug-taking behavior can overide pro-adaptive behaviors, 
such as complying with social norms (Cadet et al., 2014). In many instances, the desire 
to quit these behaviors is not enough to stop the motivation to take the drug. 
 Drug cravings continues even after rewarding efects of the drug are no longer 
considered euphoric (Russel, 1976; Baker et al., 1987), and are often triggered by drug-
associated stimuli (Miler, 2013a). Even re-exposure to subconsciously drug-associated 
stimuli can drive relapse behavior (Childress et al., 2008), often after long periods of 
abstinence (Miler, 2013a). For many cases of adiction, mal-adaptive behaviors and 
relapse take a tol on the emotional and economic prosperity of addicts, their families, 
as wel as society (Godfrey et al., 2004; NIDA-InSite, 2017). Research to understand 
and manipulate the biological underpinnings of learned associations in addiction wil 
help aleviate these burdens, but additionaly have the potential to benefit other diseases 
involving memory by uncovering basic mechanisms that encode learning. 
2.  Model organisms to study the brain 
To ask questions about mal-adaptive learned associations driving addiction, studies use 
model organisms from a range of phylogenetic relatedness to humans depending on the 




(flies, worms, fish) can be useful for exploring genetic influences on learned 
associations by manipulating gene expression easily, but with severe limitations in 
comparing central nervous system adaptations (Teach.Genetics, 2013). Higher order 
organisms, such as primates, ofer paralel cognitive and learning abilities to humans 
and ofer almost analogous brain anatomy. However, primates mature slowly with long 
life expectancies making it dificult to perform genetic or developmental manipulations 
and often making studies cost prohibitive. For these reasons, rodents are more 
commonly used for modeling addiction behavior and studying relevant human brain 
changes (Miler, 2013b). 
Rodents are geneticaly similar to humans ofering reasonably equivalent brain systems 
that encode similar conditioned behaviors. Analogous proteins, cel types, brain 
structures, and behavior expression are seen for many diseases including addiction. 
Most common rodent models include mice and rats, which each have slight advantages 
and disadvantages (Teach.Genetics, 2013). Mice have a longer history of genetic 
manipulation making answers to developmental and cellular mechanism questions more 
available, while rats tend to have more easily discerned cognitive abilities. However, 
extreme similarities between rats and mice alow for many generalizations between 
rodent models, ofering a rich literature for studying learning. In the folowing we wil 
not explicitly indicate findings for rats or mice unless they are found to be diferent, in 
which case findings for rats are used. 
3.  Behavior models of addiction 
Rats have been shown consistently to model two major types of learning used in 




Both types of learning require learned associations to form in the brain between stimuli 
and reward, but encode diferent approaches (Bouton, 2007). 
Operant learning is goal-directed learning, where rats perform voluntary responses to 
obtain rewards or avoid punishments. In many operant learning experiments studying 
learned associations, rats are taught to self-administer rewards by interacting directly 
with cues, for example pressing a lever to receive food pelets. A variety of 
observations and manipulations of this learned self-administration during acquisition, 
abstinence, extinction, and reinstatement after extinction, as wel as tests on other 
appetitive and aversive operant learning tasks, have uncovered lots about encoding of 
goal-directed learning.  
Contrasting goal-directed learning, Pavlovian learning is an involuntary, conditioned 
learning that alows for neutral stimuli to become associated with inherently rewarding 
properties of drugs upon experimenter-administration (Bouton, 2007). One example of 
traditional Pavlovian addiction-related behavior includes conditioned-place preference. 
In conditioned-place preference experiments, a novel environment is paired with drug 
administration, and conditioned learning leads to observable preferences for the reward-
paired context. Factors such as dose, duration, frequency and context al play a role in 
how quickly conditioned learning occurs (Bouton, 2007; Schuweiler et al., 2018b). 
Observation and manipulation of this learned preference during acquisition, extinction, 
and reinstatement have identified relevant brain areas, cel types, and neuronal 
ensembles related to learned associations in rodents. A second, important type of 





3.1.  Behavioral sensitization to stimulants 
Behavioral sensitization occurs when intermitent, repeated administration of a stimulus 
results in progressive amplification of a behavioral response (Robinson and Becker, 
1986). After conditioned learning has occured to establish behavioral sensitization, for 
example after repeated amphetamine administration in a novel context, subsequent, 
acute injections of amphetamine should elicit behavior normaly seen at higher doses of 
the drug (Neil et al., 1974; Kalivas et al., 1993). It is important to avoid neurotoxicity 
from extreme drug exposure to study behavioral sensitization (Robinson and Becker, 
1986; Yoon et al., 2016). Diferent behaviors can be sensitized preferentialy at 
diferent rates by diferent sensitization protocols explained more below.  
It is hypothesized that the phenomenon of behavioral sensitization is a product of neural 
adaptations of the brain's reward circuitry similar to adaptations occurring in addiction 
learning (Robinson and Becker, 1986; Kalivas et al., 1993; Schuweiler et al., 2018a). 
Because repeated administration often occurs with a variety of novel stimuli, such as 
injections, handling, or environment used to record behaviors, for many studies it can 
be dificult to dissociate learned aspects of behavioral sensitization from 
pharmacokinentic aspects (Robinson and Becker, 1986). 
Fortunately, there are ranges of behaviors that become sensitized with repeated 
administration of stimulants that seem to be expressed by diferent aspects of learning 
and drug efects. The administration method, dose, duration, administration frequency, 
withdrawal period, test conditions, and contextual stimuli al play a role in the 
behavioral sensitization response. Intermitent, repeated amphetamine administration is 




bobs, licking behaviors, and excessive grooming are varieties of restrictive sensitization 
behavior (Neil et al., 1974), while locomotor sensitization, most often measured as 
distance traveled, relies on sensitization of hyperlocomotion. Locomotor sensitization is 
proposed to later promote the seeking and self-administration of psychostimulants, 
making it an addiction-related behavior that may underlie the transition from casual 
drug use to compulsive drug taking and abuse (Vezina et al., 2002). Additional 
measures of locomotor sensitization can be made by quantifying number of rears, 
rotations (Robinson and Becker, 1986). More recently even ultrasonic vocalizations of 
rats have been used to determine sensitization (Costa et al., 2015; Kaniuga et al., 2016). 
Diferent sensitization protocols have tendencies to elicit diferent sensitized behavior 
outputs, with higher doses during repeated administration or testing typicaly inducing 
more restrictive stereotypic efects and lower doses during repeated administration and 
testing inducing hyperlocomotor efects, and a scoring system for stereotypic activity 
quantifies these diferences (Elinwood and Balster, 1974). It is important to note that 
sensitized restrictive stereotypies can interfere with locomotor sensitization, and 
precautions to address the interference may be required to properly measure 
sensitization. 
To test drug doses that induce locomotor sensitization, comparisons between rats 
repeatedly injected with a simulant are made to rats repeatedly injected under the same 
conditions with saline to control for drug-specific efects versus non-drug protocol 
efects or acute stimulant efects. Stil, there is no single protocol for sensitization, and 
many variations elicit robust locomotor sensitization (Badiani et al., 2000). However, it 




increased locomotor activity to amphetamine-induced sensitization can be context-
specific (Badiani et al., 1997). 
3.2.  Context-specific locomotor sensitization 
 When a novel environment is paired with a stimulant, such as amphetamine, 
properties of the context have been known to induce a conditioned locomotion, 
presented as locomotor sensitization with no drug on board. In these cases, associated 
stimuli from the context are enough to induce a sensitized locomotor response. 
However, presence of conditioned locomotion is not a requirement of context-specific 
locomotor sensitization (Robinson and Becker, 1986; Badiani et al., 1995; 
Anagnostaras and Robinson, 1996; Anagnostaras et al., 2002). 
 In studies controling for learned associations that induce locomotor sensitization 
in a context-specific manner, rats can be repeatedly administered amphetamine in one 
of a variety of contexts or tested in a variety of contexts for locomotor sensitization. It 
is clear that conditioning in a novel context, sometimes caled "third world" 
environment, elicits beter locomotor sensitization than repeatedly administered drug in 
a rat's familiar home cage (Badiani et al., 1995; Anagnostaras and Robinson, 1996; 
Badiani et al., 2000; Anagnostaras et al., 2002). It is hypothesized that the increased 
glutamate released in response to a novel environment alows for greater sensitization 
to amphetamine at lower administration and test doses. 
 Regardless of the mechanisms, the result of this novel-context conditioning is the 
expression of locomotor sensitization only when rats are acutely chalenged with a drug 




mechanisms encoding context-specific locomotor sensitization can provide input to 
future therapeutic developments for drug addiction. 
4.  Anatomy of behavioral sensitization 
Because stimulants, such as amphetamine, that induce behavioral sensitization are 
known to influence the tone of dopamine in the brain by altering dopamine release at 
the transporter, extensive research has been done on the midbrain dopamanergic system 
to understand learned associations (Kalivas, 2004). Though other receptor systems in 
the brain have been afiliated with amphetamine sensitization (Everit and Robbins, 
2005; Zaniewska et al., 2015), dopamine is the most widely studied. 
The midbrain dopamanergic system includes multiple brain regions mirored across 
hemispheres, but also encompasses the limbic system. The limbic system is often 
credited for the function of motivation, learning, and memory. Midbrain limbic areas 
include amygdala, hippocampus, thalamus, hypothalamus, habenula as wel as others. 
Many of these areas provide input to the basal ganglia. The basal ganglia is a group of 
subcortical nuclei that connect cortex, thalamus and brainstem, as wel as functionaly 
defined subcortical areas. There are two, paralel projection pathways in the subcortical 
basal ganglia. One circuit known for its involvement in learned movement as wel as 
heavily conditioned reward learning and includes dorsal striatum, globus palidus and 
substantia nigra, while new reward learning is canonicaly considered to occur through 
ventral striatum, ventral palidum, and ventral tegmentum (Smith and Kieval, 2000). 
However, it is noteworthy that both basal ganglia circuits have been shown to play roles 
in motor-action planning, decision-making, learned-reinforcement, and motivation, and 




The majority of brain dopamine, which is projected vastly to areas of the midbrain 
dopamanergic system, is synthesized in the two smal basal ganglia areas, substantia 
nigra and ventral tegmentum (Luo and Huang, 2016). The striatum is a primary target 
of these dopamine projections and appropriately rich in G-protein-coupled dopamine 
receptors. Dorsal striatum is often subdivided into caudate and putamen, with extensive 
evidence of its involvement in planned motor function and habituated behavior, while 
ventral striatum is subdivided into nucleus accumbens and olfactory tubercle in rats and 
humans. The nucleus accumbens is often a targeted site of research for addiction 
because of its role in reward learning, particularly newer learned associations. Nucleus 
accumbens and has been proven repeatedly to play a pivotal role in behavioral 
sensitization, making it a prime region for studying conditioned learning. 
4.1.  Nucleus accumbens 
 In rats and humans, each hemisphere of the brain has its own nucleus accumbens 
comprised of a colection of neurons and described as having an inner core and outer 
shel. These sub-structures are appropriately named accumbens core and shel 
diferentiated mainly by function. Functional diferences are highlighted by aferent 
projections, eferent projections, and few morphological distinctions in the density and 
arborization of neurons. Structuraly, the accumbens core resides around the anterior 
commissure, and accumbens shel wraps around the medial-ventral edge of the core. 
Both regions touch the tip of the lateral ventricle and vary in size and shape in their 
rostral to caudal assembly. More recently, the shel has been further broken into lateral, 
medial, and dorsomedial regions based on activity and function, though these 




 Aferents from limbic regions, such as prefrontal cortex, amygdala, thalamus, 
and hippocampus are glutamatergic, releasing the excitatory neurotransmiter 
glutamate, and project to both the core and shel. These aferent areas can be 
subdivided, and often preferentialy innervate the accumbens core or shel diferentialy 
by aferent sub-areas. The primary source of dopamine projections to ventral striatum is 
the ventral tegmentum, which topographicaly innervates the nucleus accumbens 
(Clarke and Adermark, 2015). 
 Eferent projections from the nucleus accumbens are GABAergic, releasing the 
inhibitory neurotransmiter GABA. These GABAergic outputs mainly project to the 
thalumus and ventral palidum with downstream targets in cortical areas known to 
regulate motor planning and execution. In this way, the nucleus accumbens can 
indirectly influence aferent brain areas to control the tone of glutamate in the nucleus 
accumbens. Some of the functional distinctions between nucleus accumbens areas can 
be understood by the eferent projections of medium spiny neurons. 
 Accumbens core is often considered more similar to the dorsal striatum with 
known involvement in motor programming of acquisition of learned behaviors. The 
accumbens shel is thought to more abstractly encode motivational salience and 
subjective interpretation, such as "liking" (Beridge et al., 2009). Stil, some studies of 
accumbens core and shel find the functional roles of these areas can act in direct 
opposition for a given behavior (Selings and Clarke, 2003; Ito et al., 2005; Clarke and 
Adermark, 2015). Though there are constant discoveries chalenging the rigidity of 
canonical functions atributed to the striatum, generalizations ofer some insight to their 




 It is worth noting that there is amassed evidence that brain systems outside the 
basal ganglia are also involved in behavioral sensitization and other addiction-related 
behaviors. Similarly, although dopamine has a clear role modulating addiction and 
motivation, it is not optimized to induce hedonic learning without glutamate (Badiani et 
al., 2000; Ostrander et al., 2003). Given the single source of dopamine and multiple 
sources of glutamate innervating the accumbens, it is logical that glutamate would have 
clear role in manipulating accumbens signaling and thusly accumbens encoded 
behavior. With known roles for dopamine and glutamate in the case of behavioral 
sensitization, cue-dependent plasticity of neurons has been found repeatedly in both 
accumbens core and shel (Nestler, 2001; Kalivas, 2004). 
4.2.  Cel-type distribution in the nucleus accumbens 
 Although accumbens shel and accumbens core are considered distinct sub-areas, 
they have similar celular architecture. In both areas, >90% of nucleus accumbens 
neurons are GABAergic medium spiny neurons acting as the primary output of 
accumbens. They are named so because of their morphology. They are uniform in size 
and have extensive dendritic arbors covered in dendritic spines, which are specialized 
sub-structures designed to expertly integrate glutamatergic and dopaminergic input.  
 Medium spiny neurons of the nucleus accumbens can be further subdivided into 
two distinct populations: D1-receptor-expressing and D2-receptor-expressing (Pereault 
et al., 2010). They are Go- and Gi-coupled proteins, respectively, acting through 
diferent cel signaling processes in relative-opposition. In normal working brains, 
diferent signaling pathways of these dopamine-receptors are found to play 




they are not restricted to unidirectional plasticity (Shen et al., 2008). They are the two 
most extensively studied dopamine-receptors in addiction, with younger studies 
accounting for expression and roles of D3-, D4-, and D5-receptors (Adinof, 2004; Sun 
et al., 2016). In the accumbens, approximately half the neurons are shown to be D1-
receptor-expressing, while the other half are D2-receptor-expressing, with few 
instances of receptor co-expression (Pereault et al., 2010; Thibault et al., 2013). D1- 
and D2-receptor subtypes are found in the nucleus accumbens to co-express enkephalin 
or dynorphin, respectively (Steiner and Gerfen, 1998; Smith et al., 2013). Though 
GABA is the primary output of the medium spiny neurons, these unique opioid 
receptors ligands co-release on to target brain regions alowing for diferential 
messaging post-synapticaly (Steiner and Gerfen, 1998). Though less evidence for 
divergence of D1- and D2-receptor-expressing pathways is found in for in nucleus 
accumbens than dorsal striatum "direct" and "indirect" signaling pathways (Smith et al., 
2013), these distinct dopamine-receptor-expressing neurons of accumbens are thought 
to have somewhat divergent roles in addiction. 
 Recent studies have shown that D1- and D2-receptor-expressing neurons have 
antagonistic efects on drug related behaviors. In some studies activation of D1-
receptor-expressing neurons and inactivation of D2-receptor-expressing neurons show 
enhanced sensitivity to drugs (Lobo et al., 2010) or the reverse (Yoon et al., 2016), 
most likely dependent on drug, dose, and timing (Kai et al., 2015). In some cases 
diferent results have been seen for rats and mice in dopamine-receptor responses (al-
Tajir et al., 1990; Ralph-Wiliams et al., 2003; Matson et al., 2007a; Smith et al., 




diferentialy regulated for D1- and D2- receptor neurons (Surmeier et al., 2007). 
Though findings with amphetamine sensitization have indicated that the expression of 
diferent dopamine-receptors, by measuring associated dynorphin and enkephalin 
proteins, indicate equal recruitment of D1- and D2-receptor-expressing neurons of the 
striatum (Jaber et al., 1995; Matson et al., 2007a). 
 However, medium spiny neurons do not simply provide eferent projections. 
There is some lateral regulation between medium spiny neurons, though primary 
inhibition of nucleus accumbens output comes from the remaining, diverse population 
of interneurons (Clarke and Adermark, 2015). 
 Each of the interneuron subtypes make up a total of 5-10% of accumbens neurons, 
with each subtype claiming ≤1% of the total accumbens makeup. Morphologicaly 
contrasting medium spiny neurons are striatal cholinergic interneurons. Though smal 
in number, these neurons are large, aspiny cels with extensive axonal branching 
heavily influencing striatal function. They play a crucial role in the depolarization of 
medium spiny neurons by acetylcholine, with fewer projections found to other 
interneurons (Lim et al., 2014). The remaining heterogeneous population of 
GABAergic interneurons potentiates medium spiny neurons with strong inhibitory 
innervation. There are various distinct populations of GABAergic interneurons 
categorized by diferences in spike rate and spike threshold. Conventional subtypes of 
GABAergic interneurons are delineated by protein expression, for example expression 
of parvalbumin, neruopeptide Y, nitric oxide synthase, somatostatin, calretinin and 




 In addition to studying cel-type roles and diversity in the accumbens, 
expression of many transient factors, such as immediate early genes, for example 
ΔFosB, ERK, Fos, Zif268, Egr-1, to name a few, have also been found after chronic 
drug use (Hope et al., 1994; Crombag et al., 2002; Lobo et al., 2010). Many of these 
transient makers, particularly the Fos-family proteins, are found across cel subtypes 
after behavioral sensitization and reliably mark activated neurons. 
5.  Neuronal ensembles 
 There is a high-degree of resolution needed to encode learned associations 
between rewarding efects of drugs and complex cues of stimuli. Initial atempts to 
understand the encoding mechanisms of learned associations were primarily done by 
analysis of whole brain area, and later, when possible, divided by cel subtypes as just 
explained for the nucleus accumbens. However, neither of these methods provides 
enough resolution or required subtlety to encode the dynamic number of complex 
behaviors rats and humans can exhibit through learned associations. Adaptations of a 
theory first proposed mid-20th century by Donald Hebb has transformed into the more 
modern neuronal ensemble hypothesis. It theorizes that learned associations are 
encoded by sparsely distributed, synchronously activated neurons (Cruz et al., 2015). 
 Initial studies of activated neurons were done with single-unit recordings, and 
showed support for the role of neuronal ensembles to encode addiction-related learning. 
Recordings of firing rate in response to addiction models, such as self-administration 
(Cruz et al., 2015) and conditioned place preference (Faust et al., 2013), revealed 




of phasic firing occuring instead for cues and context of drug-associated stimuli, even 
when drug is not on board.  
5.1.  Fos-expressing neuronal ensembles 
 Within the last two decades, advances in rodent genetics and genetic 
manipulation, have provided the methods to more selectively observe and target 
neurons activated during behavior (Cruz et al., 2015). New, successful methodologies 
for creating transgenic rats and viral vectors have provided a unique opportunity to 
study specificaly-activated neuronal ensembles, and test if and how they are encoding 
addiction-related behavior. The best candidates for time-locked identification of 
specificaly activated neurons are transiently activated immediate early genes known to 
be transcriptionaly up-regulated after behavior changes in activated neurons, for 
example, Fos, zif268, and arc (Lobo et al., 2010). Immediate early gene promoters, 
which ofer low baseline transcription and fast onset of transcription after cel 
hyperpolarization, are ideal for studying neuronal ensembles by promoting designer 
genes that can be caried in viral vectors and microinjected into the brain or transgenic 
rat models. 
 Though a variety of promoters for immediate early genes exist to test neuronal 
ensembles, the Fos-promoter is the obvious candidate for expressing exogenous genes 
to identify and manipulate neurons. For many reasons, including ease of labeling, Fos is 
the most widely used marker of neuronal activation in the literature. As such, its 
promoter is wel understood. It is activated by calcium dependently phosphorylated 
transcription factors, namely through ERK/MapK signaling. Peak mRNA Fos 




expression peaks approximately 90-minutes after cel activation and is degraded within 
a few hours. It is part of the Fos-family of proteins, which include the immediate early 
genes Fra-1, Fra-2, FosB and ΔFosB (Chen et al., 1997). Of these, ΔFosB has some 
distinct features from Fos.  
 ΔFosB is an alternatively spliced variant of the FosB gene, which accumulates 
after repeated drug exposure or stress. This splice variant is missing two degredation 
domains in the C-terminus, and is phosphorylated at the N-terminus providing high 
protein stability. Its half-life is approximated to be 9-days and has been found at time 
points several weeks after neuron activation. After repeated activation of nucleus 
accumbens neurons by drugs of abuse, ΔFosB becomes the predominant Fos-like 
protein (Nestler, 2012). These contrasting factors make Fos a great marker for acute 
activation, and ΔFosB an optimal marker for previously repeated activation. 
Additionaly, expression of Fos and ΔFosB was shown to be increased in response to a 
variety of behavioral sensitization protocols (Winstanley et al., 2009; Beloate et al., 
2016b; Carneiro de Oliveira et al., 2016), and possibly species specific (Conversi et al., 
2011). However, it has been shown manipulations and treatments after sensitization 
conditioning that blocked behavioral sensitization output did not afect ΔFosB 
expression (Beloate et al., 2016b). This indicated ΔFosB was induced by activity prior 
to an acute amphetamine chalenge injection and not sensitization expression on test 
day. 
5.2.  Transgenic rats to study Fos-expressing neuronal ensembles 
 Development of two major transgenic rat lines that utilize the Fos-promoter have 




which contains a transgene encoding for a fluorescent FosGFP fusion protein, has 
alowed the uncovering of unique electrophysiological and molecular alterations of 
Fos-expressing neuronal ensembles encoding learned associations to reward. Second, 
the Fos-LacZ transgenic rat, which contains a transgene encoding for the enzyme β-
galactosidase, have alowed for manipulation of Fos-expressing neuronal ensembles, as 
wel as labeling with X-gal labeling. 
 In Fos-LacZ transgenic rats, expression of β-galactosidase is inert to endogenous 
substrates, but can cleave the pro-drug Daun02 inducing cel apoptosis. In the Daun02 
inactivation procedure, neurons provoked to hyperpolarize on an "induction day test," 
activate the Fos-promoter. Approximately 90-minutes after peak induction, inter-
cranial microinjections of Daun02 into target brain areas result in ablation of suspected 
Fos-expressing neuronal ensembles (Smith and Aston-Jones, 2009; Koya et al., 2016). 
Using this technique, experiments to determine the causal role of Fos-expressing 
neuronal ensembles on learned drug-associations and behavior have shown atenuation 
of addiction-related behavior after Daun02 inactivation (Fanous et al., 2012; Cruz et al., 
2014; Waren et al., 2016; Whitaker et al., 2017). 
 More specificaly, in cocaine-induced locomotor sensitization, Daun02 
inactivation of Fos-expressing neuronal ensembles indicated these cels played a causal 
role. This was tested again in a context-specific manner, where rats were trained in 
locomotor chambers with repeated cocaine or saline, given 1-week withdrawal, and 
after an induction day session either in the locomotor chamber or novel context, 
microinjected with Daun02 or vehicle in the nucleus accumbens. Later, a locomotor test 




context-specific manner, where rats induced in the locomotor chamber had reduced 
sensitization compared to rats induced in the novel context (Koya et al., 2009). 
 These Fos-expressing neuronal ensembles with a known causal role in 
addiction-related behaviors have been found to be limited to 1-5% of neurons in studied 
brain areas. The smal number and distinct paterns of Fos activation easily permit Fos-
expressing neuronal ensembles the resolution needed to encode a variety of learned 
associations (Koya et al., 2009; Whitaker et al., 2016). 
6.  Experimental summary and hypothesis 
 For the experiments of this thesis, we studied learned associations of locomotor 
sensitization by pairing contexts with repeated amphetamine administration. We 
expected changes in Fos expression throughout the nucleus accumbens in response to 
locomotor sensitization, and characterized this population by (i) analyzing potential 
diferences of Fos expression in the shel and core, (i) determining recruitment of 
nucleus accumbens dopamine-receptor expressing subtypes to the Fos-expressing 
ensemble, (ii) determining the overlap of ΔFosB-expressing neurons labeled by 
activation during sensitization conditioning with repeated administration of 
amphetamine and Fos-expressing neuronal ensembles we believe are encoding 
behavior. We designed control experiments to prove context-specificity of our 
locomotor sensitization protocol, and eventualy evaluated the causal role these Fos-
expressing neurons play in context-specific locomotor sensitization to amphetamine 
with Daun02 inactivation. Ultimately, we propose that Fos-expressing neuronal 
ensembles of the nucleus accumbens encoding context-specific sensitization are playing 





























1.  Subjects 
Male Long-Evans rats (Charles River, Raleigh, NC), weighing 300-600g, were used for 
most experiments. Where indicated, certain experiments required use of male Fos-GFP 
transgenic rats bred in a Long-Evans background, while other experiments utilized 
male FosLacZ transgenic rats bred in a Sprague-Dawley background. Al breeding was 
done at NIDA, BRC (Baltimore, MD) by NIDA OTTC (Vautier, 2017).  
Behavioral experiments lasted 3-4 weeks. Al rats were watered and fed ad libitum in 
standard sized home cages. They were housed on a 12-hour reverse-light cycle (8am-
8pm), and experiments were conducted during the active (dark) cycle. Rats were group 
housed with cage-mates (2-3 rats) undergoing the same repeated drug administration 
protocol. With few exceptions (veterinary recommendation, unexpected death of a cage 
mate mid-study, etc.) rats remained pair housed for the duration of the experiment. Rats 
were acclimated to these housing conditions for a minimum of 7 days prior to drug 
treatments. Al rats not sacrificed for histology were humanely euthanized. 
Some rats run in behavior tests described below were excluded from analyses if they 
died unexpectedly, were flagged unfit for experiments by veterinary staf, weighed over 
600g and locomotor activity scores were impeded (belies dragged, injections could not 
be guaranteed i.p.), were tested in locomotor chambers exhibiting equipment 
malfunctions (erors in beam break recordings, etc.), or found post-mortem to have 
brain infections or cysts.  
2.  Facilities 
Al experiments were conducted at the NIDA BRC under the guidelines of the NIH and 




180. Facility temperatures were maintained at 70oC with 80% humidity. Experiments 
and surgeries were conducted in separate rooms from housing in the animal facility.  
3.  Drug treatment and behavioral assays 
 Amphetamine (d-amphetamine) was purchased from Sigma-Aldrich (cat# 51-
63-8) and diluted in 0.9% sterile, injectable saline. 
3.1.  Experiment 1: Repeated drug administration protocol for locomotor 
sensitization 
 To initiate experiments, rats were given 5-days of conditioning. Each day rats 
were taken from their home cage and administered an intraperitoneal (i.p.) injection of 
amphetamine (2 mg/kg; n = 25) or saline vehicle (1 ml/kg; n = 23) and immediately 
placed into dimly lit locomotor activity chamber for 120 minutes (for timeline see 
Chapter 2, Figure 1A). The locomotor activity chamber (Med Associates, ENV-515-
43x43x43cm) was lined with infrared photo-beams used to monitor the location of the 
rat in the chamber, as measured by two adjacent beam breaks. Activity Monitor 
Software (Med Associates, VT) was programmed to convert beam breaks into distance 
traveled, which was used to determine the rats' locomotor activity scores. 
 Folowing the last day of repeated drug administration, rats underwent one week 
of abstinence in their home cage, during which no drug was administered. Finaly, on 
test day, rats were brought to the experiment room. Here, rats from each repeated drug 
administration group were acutely injected (i.p.) with amphetamine (0, 1, 2 mg/kg; 
amphetamine, n = 8, 9, 8; saline, n = 7, 9, 7) and immediately placed in the locomotor 




sampled from each test group, restrictive stereotypy was manualy scored during 
testing. 
3.2.  Experiment 2: Protein expression after locomotor sensitization 
 Rats were repeatedly administered amphetamine (2 mg/kg) or saline (1 ml/kg)  
in locomotor activity chambers once daily for 5 days, as described in Experiment 1. 
Folowing the last day of repeated drug administration, rats underwent one week of 
abstinence in their home cage. Finaly, on test day, rats were brought to the experiment 
room. Here, rats from each repeated drug administration group were acutely injected 
(i.p.) with amphetamine (0, 1 mg/kg; n = 10, each group) and immediately placed in the 
locomotor chamber. To capture maximal Fos expression (Mugnaini et al., 1989), at the 
end of the 90-minute test session, rats were deeply anesthetized (isofluorane) and 
perfused transcardialy with 150 mL 0.1 M phosphate-bufered saline (PBS) folowed 
by 500 mL 4% paraformaldehyde in 0.1 M sodium phosphate (pH 7.4) (PFA). Perfused 
brains were removed and post-fixed in 4% PFA overnight and transfered to 30% 
sucrose in PBS (pH 7.4) at 4 oC until brains sank (approximately 3 days). Brains were 
then flash-frozen in powder dry ice and stored at -20 oC until sectioning for Fos 
immunohistochemistry. In a separate experiment, 14 additional rats were added to the 
experiment, and grouped to receive conditioning (amphetamine or saline), testing (0 or 
1 mg/kg amphetamine), and brain tissue preparation exactly as outlined above, before 
being utilized for ΔFosB immunohistochemistry.  
3.3.  Experiment 3: mRNA expression after locomotor sensitization  
 Rats were repeatedly administered amphetamine (2 mg/kg; n = 6) or saline (1 




Experiment 1. Due to resource constraints, we limited our acute injection on test day to 
1 mg/kg, prioritizing the observation of rats exhibiting locomotor sensitization while 
controling for potential efects of acute amphetamine. Test sessions were truncated to 
30-minutes, to alow for sacrifice at peak Fos mRNA expression, and rats were heavily 
anesthetized with isoflurane for live decapitation. Fresh brains were carefuly removed 
and snap-frozen for 20 seconds in -50 oC isopentane, and stored in the – 80 oC freezer 
until ready for further processing.  
3.4.  Experiment 4: Protein expression after locomotor sensitization in Fos-GFP 
transgenic rats   
 Transgenic Fos-GFP rats were conditioned through the entire amphetamine 
sensitization protocol described in Experiment 2, with the same fixation protocol. 
Brains were stored in foil wrapped tubes to prevent fluorescence bleaching of GFP until 
they were flash-frozen with powdered dry ice. They were then stored at -20 oC until 
further processed for immunofluorescent colabeling of FosGFP and ΔFosB. 
3.5.  Experiment 5: Repeated drug administration protocol for context-specific 
locomotor sensitization 
 To determine if the locomotor activity and histology obtained through our 
sensitization protocol was due to context-specific learned-associations or 
pharmacological efects of amphetamine, we designed a second context (context B) in 
which rats could be sensitized (for timeline see Chapter 2, Figure 5A).  
 In an atempt to reduce potential interference of novelty exploration on locomotor 
activity recorded test day from rats sensitized in context B, al rats were given a 2-hour 




conditioning. During sensitization conditioning rats were removed from the home cage 
and, over 5 x 2-hour sessions, rats were repeatedly administered amphetamine or saline 
(i.p.) in context A (2 mg/kg amphetamine, n = 27; saline, n = 28) or context B (2 mg/kg 
amphetamine, n = 23; saline, n = 21). Context B chambers were large microinjection 
bowls (Harvard Apparatus, CMA830931, 36cm high x 30cm diameter) with 150 g of 
woodchip bedding and smal plastic toy; lights were turned of and music (Mix, 2002) 
was played continuously in the background.  
 On test day, after 1-week abstinence in the home cages, al rats were given an 
acute injection amphetamine (0, 1 mg/kg) and immediately placed in context A. Rats 
from diferent conditioning groups were distributed evenly (for n per group see section 
2. Figure 6B). At the end of the 90-minute test session, rats were heavily anesthetized, 
transcardialy perfused, and brains stored as described in Experiment 2, in preparation 
for Fos and ΔFosB immunohistochemistry.  
3.6.  Experiment 6: Repeated drug administration protocol after context-specific 
locomotor sensitization in Fos-GFP transgenic rats 
 Fos-GFP transgenic rats were sensitized to repeated amphetamine in diferent 
contexts, and tested for sensitization. Similar to Experiment 5, rats were given a 2-hour 
habituation to the testing chamber (context A) prior to sensitization conditioning to 
reduce interference of novelty exploration on test day (for schematic see Chapter 2, 
Figure 6A). Fos-GFP rats received 5 sessions of repeated administration of 
amphetamine (2 mg/kg) in context A (n = 7), context B (n = 7), or the home cage (n = 
3). Rats sensitized in context A and B were returned to the home cage after 2-hours. 




amphetamine (1 mg/kg) prior to a 90-minute locomotor activity test in context A. 
Immediately after testing rats were anesthetized, transcardialy perfused, and brains 
stored as described in Experiment 4, in preparation for FosGFP and ΔFosB 
immunofluorescent colabeling. 
3.7.  Experiment 7: Daun02 inactivation after context-specific locomotor 
sensitization in Fos-LacZ transgenic rats 
  To use the Daun02 inactivation procedure in assessing the causal role of Fos-
expressing neuronal ensembles on context-specific locomotor sensitization, 
modifications to Experiment 5 were made (for schematic see Chapter 2, Figure 7A). 
First, the Daun02 inactivation procedure required the implantation of guide cannula (23 
gauge; Plastics One) bilateraly, 1 mm above the nucleus accumbens. We anesthetized 
FosLacZ transgenic rats with isofluorane and secured them in a Kopf digital-stereotax. 
The nose bar was set at -3.3 mm, and the coordinates used to target the nucleus 
accumbens shel were anteroposterior +1.6, mediolateral ± 2.3 (10 ° angle), and 
dorsoventral -7.5 mm from rats’ Bregma. Cannula were permanently fixed to the rat’s 
skul with dental cement and jeweler’s screws. To reduce pain during recovery, rats 
were injected with Ketoprofen (2.5 mg/kg, sub cutaneous) for up to 3 days post-
surgery. Rats were given at least one week to fuly recover before beginning 
sensitization. 
 Experimental procedures for sensitization conditioning were exactly the same as 
Experiment 5 including context A habituation, 5 x 2-hour sessions of repeated 
amphetamine or saline administration in context A (amphetamine, n = 20; saline n = 




was reduced to 6-days to alow for a Fos-induction session on day 6 after the last 
session of sensitization conditioning.  
 On Fos-induction day, al rats were removed from the home cage and acutely 
injected (i.p.) with 1 mg/kg amphetamine immediately before a 90-minute locomotor 
activity test in context A. Folowing Fos-induction sessions, rats from diferent 
conditioning groups were microinjected in the testing room with either Daun02 
(Sequoia Research Products; dissolved in vehicle) or vehicle (5% DMSO, 6% Tween 
80, 89% 0.1 M PBS). Microinjections lasted 1 minute at a rate of 0.5 μg/0.5 μL/side 
using a syringe pump (Harvard Apparatus) with 10 μL Hamilton syringes atached via 
polyethylene-50 tubing to 30 gauge injectors (Plastics One) that extend 1 mm beyond 
the guide cannula into accumbens shel. Injectors were left in place for 1-minute before 
removal, and returning the rat to the home cage. 
 Three days after the Daun02 inactivation or vehicle microinjections on Fos-
induction day, al rats were tested for locomotor activity in context A for 90-minutes 
imediately folowing an acute injection of 1 mg/kg amphetamine (i.p.). Immediately 
folowing the test session, rats were deeply anesthetized, trandscardialy perfused, and 
brains stored exactly as described in Experiment 2, in preparation for X-gal labeling.  
4.  Histology 
 For al immuno- labeling sections were kept free floating, al wash steps lasted 10 
minutes and were done in triplicate, and al washes and incubations were conducted on 






4.1.  Immunohistochemistry labeling 
 Whole, fixed brains from rats in Experiment 2 and 5 stored at -20 oC for 
immunohistochemistry were coronaly sliced (40 μm sections) for nucleus accumbens 
(~+1.32 to +1.6 from Bregma) using a cryostat (Leica, CM1850 UV; -15 ℃), and 
stored free floating in PBS-azide (1 M PBS, 0.01% azide, pH 7.4) in a 4 oC refrigerator. 
4.1.1.  Fos immunohistochemistry 
 For Fos immunohistochemistry, 3-6 accumbens sections per rat were plated, and 
sections were washed in PBS. Sections were then transfered to blocking bufer (3% 
normal goat serum (NGS), 0.25% Triton X-100 in PBS (PBS-Tx) for 1-hour, and next, 
incubated over night at 4 oC with anti-Fos antibody diluted in blocking bufer (1:16000 
dilution; Cel Signaling Technology, #2250). The folowing day, sections were washed 
in PBS, and transfered to biotinylated goat anti-rabbit secondary antibody (1:600 
dilution; 1% NGS, in PBS-Tx) for 2-hours. Sections were, again, washed in PBS, and 
incubated in avidin-biotin-peroxidase complex (Vector Laboratories, ABC Elite kit, 
PK-6100) in PBS. Next, sections were triple washed in PBS, and developed in 3,3’-
diaminobenzidine (DAB) for approximately 4-minutes, rinsed in PBS and mounted 
onto chrom-alum/gelatin-coated slides. Once dry, slides were dehydrated through a 
graded series of alcohol (30, 60, 90, 95, 100, 100% ethanol) and cleared with Citrasolv 
(Fisher Scientific) before coverslipping with Permount media (Sigma-Aldrich).  
4.1.2.  ΔFosB immunohistochemistry 
 For ΔFosB immunohistochemistry the exact same protocol as described above in 




antibody with anti-ΔFosB antibody in blocking bufer (1:100,000 dilution; Cel 
Signaling Technology, #2263).  
4.2.  Dual-immunofluorescence labeling 
4.2.1.  Fos and NeuN co-immunofluorescence 
 For a subset of rats in Experiment 2 (n = 7) that were amphetamine sensitized and 
injected with 1 mg/kg amphetamine on test day, a set of nucleus accumbens brain 
sections were fluorescently labeled for anti-Fos and anti-NeuN antibodies to determine 
the percentage of Fos-expressing neurons in the nucleus accumbens.  
 For Fos and NeuN dual-immunofluorescence labeling, 2-4 accumbens sections 
per rat were plated, and sections were washed in Tris-bufered saline (TBS) (0.025 M 
Tris-HCl, 0.5 M NaCl, pH 7.4). Sections were then incubated for 20 minutes in 0.2% 
Triton X-100 in TBS (TBS-Tx) before 48-hour dual-incubation at 4 oC with anti-Fos 
antibody (1:2000 dilution) and anti-NeuN antibody (1:2000 dilution; Chemicon) diluted 
in TBS-Tx. Next, slices were washed in TBS, and al remaining steps were done in the 
dark. Dual incubation with Alexa-488 anti-mouse secondary antibody (1:200 dilution; 
Jackson Labs) to label Fos, and Alexa 568 anti-rabbit secondary antibody diluted in 
TBS-Tx (1:200 dilution; Jackson Labs) to label NeuN lasted 1-hour. Sections were 
given a final wash in TBS, and mounted on chrom-alum/gelatin-coated slides. Slides 
were coverslipped with Mowiol mounting solution (24% glycerol, 9.6% Mowiol, 2.5% 
DABCO, diluted in 50% TBS (pH 8), and 25% distiled water) and stored at 4 oC. 
4.2.2.  Fos and FosGFP co-immunofluorescence 
 Whole, fixed brains from stored at -20 oC for immunofluorescent labeling were 




transgenic rats used in Experiments 4 and 6, precautions to reduce light exposure were 
made, and sections were stored free floating in PBS-azide at 4 oC. Since the anti-Fos 
and anti-ΔFosB antibodies were created in the same host (rabbit), we utilized the 
FosGFP fusion protein expressed by FosGFP transgenic rats to label Fos-expressing 
neurons with anti-GFP antibody.  
 To verify the same neurons were being labeled by anti-Fos and anti-FosGFP 
labeling we ran a dual-immunofluorescence labeling protocol exactly as described in 
section 4.2.1. for Fos/NeuN labeling using a subset of rats (n = 12). We replaced anti-
NeuN antibody with anti-GFP antibody (1:2000 dilution; Cel Signaling Technology, 
#2955). Alexa-488 anti-mouse secondary labeled FosGFP-expressing neurons, and 
Alexa-568 anti-rabbit labeled Fos-expressing neurons. Al procedures for mounting, 
coverslipping, and storage were the same. 
4.2.3.  Fos and ΔFosB co-immunofluorescence 
 Al rats from Experiments 4 and 6 underwent FosGFP and ΔFosB dual-
immunofluorescence labeling. FosGFP/ΔFosB dual-fluorescence-labeling utilized the 
exact same protocol described above in section 1.4.2.2. used for Fos/FosGFP, replacing 
the anti-Fos antibody with anti-ΔFosB antibody (1:10,000 dilution).  
4.3.  RNAscope in situ hybridization labeling 
 Whole, fresh brains from rats in Experiment 3 stored at -80 oC for RNAscope in 
situ hybridization labeling were slowly thawed to -18 oC and coronaly sliced for 
nucleus accumbens (16 μm sections) using a cryostat. Generaly, 3-5 slices per rat were 
immediately mounted onto chiled Superfrost Plus Slides (Fisher Scientific, #12-550-




 For RNAscope in situ hybridization labeling, slides were fixed by immersion in 
chiled 10% Formalin (Fisher Scientific) for 20-minutes at 4 oC, and transfered to PBS. 
Sections were dehydrated through a graded series of alcohol (50, 70, 100% ethanol). 
Ful protocol details of washes, protease incubations, and amplification steps was 
previously described (Rubio et al., 2015). In brief, we used probes (ACDbio) designed 
to label the D1-receptor (D1-r; ACDbio, Rn-DrD1a), D2-receptor (D2-r; ACDbio, Rn-
Drd2-C2), and Fos (ACDbio, Rn-Fos-C3) mRNA in the rat brain. Probes were mixed 
to a 1x 1:1:1 dilution, and incubated for 2-hours at 40 oC. After a series of amplification 
steps, we labeled half the slices with an amplifier to labeled D1-r with Alexa 488, D2-r 
with Ato 550, and Fos with Ato 647 (Amp4 Alt A). The other half of slices were 
labeled so D1-r and D2-r had the inverse label (D1-r with Ato 550; D2-r with Alexa 
488), while Fos remained the far-red channel (Amp4 Alt B). Sections were then 
washed, dried, and coverslipped with Mowiol containing 0.15% DAPI. Slides were 
stored at 4 oC. 
4.4.  X-gal labeling 
 Whole, fixed brains from rats in Experiment 7 stored at -20 oC for X-gal labeling 
were coronaly sliced for nucleus accumbens (40 μm) using a cryostat. Slices were 
stored free-floating in PBS, without azide at 4 oC until labeleded. As needed, PBS was 
replaced weekly to prevent contamination of sections. 
 For X-gal labeling, sections were washed in PBS and incubated in X-gal reaction 
solution containing the folowing (in mΜ): 5 K4Fe(CN)6  ̇3H2), 5 K3Fe(CN)6, and 2.4 




PBS before they were mounted, dehydrated, and coverslipped the same as described for 
immunohistochemistry and labeling in section 4.1.1. 
4.5.  Imaging  
 Al images were taken using a EXi Aqua camera (QImaging) atached to a Zeiss 
Axioskop 2 light microscope at 20x magnification. For analysis of nucleus accumbens 
shel and core, positively labeled-nuclei from the entire image, which captured 
approximately 2.34 mm2 brain area, were included in quantification. We used iVision 
for Macintosh (Biovision; version 4.0.15) to adjust imaging parameters and, when 
necessary, normalize images. During quantification, slides were coded so experimenter 
was blind to experimental conditions.  
4.5.1.  Brightfield imaging 
 For Fos- or ΔFosB-immunolabeling, approximately 2-6 images for each rat were 
captured as bright-field images and quantified for positively-labeled nuclei. 
Quantifications were semi-automated using iVision software’s segmentation feature. 
The pixel density threshold for detecting Fos-positive nuclei was chosen to match that 
of the experimenter-determined manual quantification of a slice, and coroborated by a 
second experimenter. Fos and ΔFosB counts were averaged so that each rat contributed 
as n of 1 for accumbens shel and core.  
4.5.2.  Fluorescence imaging 
 For epifluorescence imaging of fluorescently labeled Fos, FosGFP, ΔFosB 
protein, and RNAscope-labeled mRNA, approximately 2-6 images for each rat were 
captured and quantified for positively-labeled nuclei. Images were set to a threshold of 




fluorescent channel using Fiji software (ImageJ 1.51n). When channels were merged, 
colabeling of dual-marked cels was determined by overlap of > 70% between 
channels, and then manualy quantified. Counts were averaged so that each rat 
contributed as n of 1 for accumbens shel and core final quantifications. 
5.  Data analysis 
 Locomotor activity was converted with Activity Monitor software to Microsoft 
Excel 2011 files, where it was sorted, organized, and analyzed for descriptive statistics. 
Statistical analysis, such as Pearson’s corelations, un-paired t-tests, and χ-squares were 
done in GraphPad Prism 7. Al other statistical analysis was done in IBM SPSS 23. Al 
ANOVAs (multi-factorial, three-way, two-way, one-way) and ANOVA assumptions 
tests (for data outliers, normality, homogeneity, linearity, test of sphericity, etc.) were 
done in IBM SPSS 23 in accordance with Laerd Statistical Tutorials and Software 
Guides (Laerd-Statistics, 2017). Appendix A contains details and results of 
assumptions tests. 
 For Fos and ΔFosB expression, in addition to separate ANOVAs, we also ran a 
multivariate-ANOVA (MANOVA), which alows us to compare two dependent 
variables, in this case the protein expression in the accumbens shel and accumbens 
core, together as a combined variable, measuring protein expression in the overal 
nucleus accumbens. This requires additional measurement of a Wilk’s λ distribution to 
test for diferences in variation of the dependent variables (protein expression) not 
explained by the independent variables (repeated administration x acute injection); 




 Where necessary, simple two-way and one-way ANOVAs were caried out with 
Fisher’s least significant diference (LSD) adjustments. Post-hoc tests were chosen 
based on type comparison. Within-subject comparisons were done with Sidak 
adjustments, while between-subject tests utilized Bonferoni or LSD adjustments, 
where noted. We used p < 0.05 to determine significant efects, unless otherwise noted. 




































































1.  Experiment 1: Amphetamine sensitization induced locomotor sensitization 
 The goal of this experiment was to determine an efective amphetamine 
sensitization protocol to later examine Fos-expressing neuronal ensembles that may 
encode the locomotor sensitization. 
1.1.  Repeated drug administration efects on conditioning locomotor activity 
 We observed locomotor activity across 5 sessions after repeated administration of 
amphetamine or saline, as laid out in our methods (Figure 1A). We found that across al 
conditioning sessions locomotor activity in rats injected with amphetamine was greater 
than rats injected with saline (Figure 1B). We statisticaly confirmed our finding with a 
two-way repeated measure ANOVA (repeated administration X session number), 
which yielded a significant interaction of repeated administration and session number 
[F(4,184) = 21.77, p < 0.001]. Sidak post-hoc comparisons expectedly revealed a 
significantly greater locomotor activity each session between rats repeatedly 
administered amphetamine and rats repeatedly administered saline (al sessions p < 
0.001). 
 We next found progressively sensitized locomotor activity to the dose 
amphetamine (2 mg/kg) use for repeated administration within-subject (Figure 1B). 
Sidak post-hoc analysis within subject found no significant diferences between 
conditioning sessions when rats were administered saline. However, rats administered 
amphetamine showed progressive increases in locomotor activity each session from as 
early as the second session (for al p < 0.001). However, based on findings in the 
literature, these quick sensitization results were more likely pharmacokinentic and not 




in the literature (Robinson and Becker, 1986). In order to later test for Fos-expressing 
ensembles that encode learned associations we continued experiments using repeated 
administration for 5-days, and 1-week abstinence before testing for locomotor 
sensitization. 
1.2.  Locomotor activity totals test day 
 After rats underwent repeated drug administration and 1-week abstinence, each 
repeated drug administration group received an acute dose amphetamine (0, 1, 2 mg/kg 
amphetamine) and locomotor activity was measured in a locomotor chamber (Figure 
1C). Group comparisons revealed overal diferences between repeated drug 
administration groups and acute injection groups (Figure 1C). A two-way ANOVA 
(repeated administration X acute injection) confirmed no significant interaction 
between repeated drug administration and acute injection, but exposed main effects of 
repeated administration [F(1,42) = 17.562, p < 0.001] and acute injection [F(2,42) = 
29.656, p < 0.001]. We continued with Bonferoni post-hoc adjustments to 
conservatively assess the most robust efects of sensitization between these factors. 
 Initial post-hoc examination revealed no diferences between the diferent drug 
administration groups after 0mg/kg acute amphetamine injection. This indicated our 
sensitization conditioning protocol did not elicit conditioned locomotion, a sensitized 
anticipatory response occasionaly seen after amphetamine sensitized (Robinson and 
Becker, 1986). This alowed us to use the acute injection of 0 mg/kg amphetamine as a 
baseline for locomotor activity for each repeated drug administration group from which 




 For rats repeatedly administered amphetamine, locomotor activity was 
compared between rats acutely injected with 0mg/kg to those acutely injected with 1 
mg/kg or 2 mg/kg amphetamine. Post-hoc analysis revealed significant increases in 
locomotor activity at both doses (both, p < 0.001). We next compared 1 mg/kg to 2 
mg/kg amphetamine injection, and found no significant diferences, thus requiring 
further analysis to determine an acute amphetamine injection dose for future 
experiments. 
 For rats repeatedly administered saline, locomotor activity was compared between 
rats acutely injected with 0mg/kg to those acutely injected with 1 mg/kg or 2 mg/kg 
amphetamine. Post-hoc analysis revealed increased locomotor activity only for rats 
acutely injected with 2 mg/kg amphetamine (p = 0.0007), while 1 mg/kg acute injection 
was not significantly increased from 0 mg/kg acute injection amphetamine. This 
finding showed rats acutely injected with 2 mg/kg amphetamine do not need prior 
amphetamine sensitization to induce a significantly higher locomotor activity than 
baseline. These pharmacokinetic locomotor efects found at 2 mg/kg amphetamine may 
confound future ability to analyze efects of learned behavior that induce locomotor 
sensitization, and require further analysis. 
1.3.  Binned locomotor activity test day 
 To further test for nuanced diferences between repeated drug administration and 
acute injection doses, we divided locomotor activity on test day into 18 x 5-minute 
activity bins and compared rats in diferent treatment groups (Figure 1D). A three-way 
mixed model ANOVA (repeated administration x acute injection x activity-bin) was not 




optimal locomotor sensitization for future experiments we caried out a two-way 
repeated measure ANOVAs (repeated administration x activity-bins) comparing 
repeated drug administration efects on within-subjected binned locomotor activity for 
each acute injection dose. 
 As previously found after measuring total locomotor activity on test day (above), 
analysis of binned locomotor activity after acute injection with 0 mg/kg found no 
diferences between repeated drug administration groups (Figure 1D, panel 1). There 
was no significant interaction (repeated administration x activity-bin) or main effect of 
repeated administration. However, for each repeated drug administration group there 
was a significant decrease in activity from the beginning to the end of the test session 
[F(17,2210) = 7.694, p <0.001], which likely reflects rats’ habituation to the context and 
reduced novelty exploration at the end of the session. Sidak post-hoc tests indicated 
both repeated drug administration groups first showed decreases from locomotor 
activity recorded in the first bin after 30 minutes (amphetamine, bin6, p = 0.041; saline, 
bin6, p = 0.001), and this decrease was sustained for the remainder of the session 
(amphetamine, bin7-18, p ≤ 0.001; saline, bin 7-18, p < 0.01).  
 For rats acutely injected with 1 mg/kg amphetamine on test day, we found robust 
locomotor sensitization occurs early in the test session as a result of previous repeated 
amphetamine administration (Figure 1D, panel 2). After 1 mg/kg acute amphetamine, a 
two-way ANOVA (repeated administration x acute injection) found no significant 
interaction, but revealed significant main efects of repeated drug administration [F(1,16) 
= 8.763, p = 0.009]. Sidak post-hoc analysis comparing rats previously administered 




administered rats in the first 35 minutes of the test session (bin2, p = 0.009; bin4, p = 
0.041; bin5, p = 0.044; bin7, p = 0.030), as compared to saline administered rats. Rats 
previously administered repeated amphetamine reduced locomotor activity after 45 
minutes, at which point they returned to levels comparable with the rats previously 
administered saline. The ANOVA also revealed a significant main efect [F(17,272) = 
7.94, p < 0.001], which indicated a decrease in locomotor activity from the beginning to 
end of the test session. Within-subject, Sidak post-hoc analysis comparing the first 
recorded bin to al subsequent bins revealed that rats previously administered saline 
were consistent in their locomotor activity for the duration of the test session, which 
means rats previously administered repeated amphetamine were driving the 
significance of the main efect for binned locomotor activity. Rats previously 
administered amphetamine showed decreases in locomotor activity 1-hour after acute 
injection with 1 mg/kg amphetamine and the start of the session (bin14-18, p ≤ 0.05). 
The decrease in activity at the end of the session ofers us a window, in the first hour of 
testing to measure peak locomotor sensitization efects, and highlights an ideal window 
for observing Fos expression diferences between locomotor sensitized and saline 
administered rats.  
 In rats acutely injected with 2 mg/kg acute amphetamine on test day, we found a 
diference between rats repeatedly administered amphetamine or saline (Figure 1D, 
panel 3). A two-way ANOVA (repeated administration x activity-bin) showed no 
significant interaction, and no significant changes in locomotor activity from the 
beginning to the end of the session. There was a significant main efects of repeated 




repeated amphetamine sustained were more active throughout the session than rats 
previously administered saline. However, Sidak post-hoc test comparing repeated drug 
administration groups reveal that only once, briefly, towards the end of the test session 
were there significant diferences between repeated amphetamine and repeated saline 
administration (bin14, p = 0.047). The lack of diference between repeated 
amphetamine and saline administration groups can be explained by the finding in the 
previous section comparing total locomotor activity test day, that revealed rats 
previously repeatedly administered saline increased locomotor activity to levels above 
baseline (0 mg/kg acute injection) when they were injected with 2 mg/kg amphetamine. 
This efect explains why saline groups were high, however, to explain why rats 
previously administered repeated amphetamine did not simply exhibit a more sensitized 
locomotor response, we measured for interference in locomotor activity with 
sensitization of another behavior, restrictive stereotypy. 
1.4.  Binned stereotypy scores test day 
 Restrictive stereotypy, characterized by perseverative movements in sensitized 
rats can interfere with locomotor activity (Robinson and Becker, 1986). Stereotyped 
behaviors were assessed every 5 min for 30 s each time using a 9-point rating scale 
adapted from Elinwood and Balster (Elinwood and Balster, 1974)—1: asleep; 2: 
inactive; 3: normal in place activity; 4: normal, alert, rearing, normal level of locomotor 
activity; 5: rearing, high level of locomotor activity; 6: slow paterned behaviors, no 
rearing, normal level of locomotor activity; 7: faster paterned behaviors, no rearing, 
high level of locomotor activity; 8: highly repetitive paterned behaviors in a restricted 




 In a subset of rats, we tested for interference of restrictive stereotypy across a 
90-minute test session (18 x 5-minute stereotypy-bins) (Figure 1E). A three-way mixed 
model ANOVA (repeated administration x acute injection x stereotypy-bin) showed no 
interaction. We then ran two-way repeated measure ANOVAs (repeated measure x 
stereotypy-bin) comparing repeated drug administration efects on within-subjected 
binned stereotypy scores for each acute injection dose.  
 Rats from both repeated drug administration groups showed relatively normal 
range in activity (2-4) throughout the session after acute injection with 0 mg/kg 
amphetamine, with more low activity bins at the end of the test session (Figure 1E, 
panel 1). A two-way ANOVA (repeated administration x stereotypy-bin) showed no 
significant interaction, but revealed main efects of repeated administration [F(1,4) = 
21.81, p = 0.01] and lower scores at the end of the test session [F(17,68) = 2.329, p = 
0.007]. These findings paralel decreases seen at the end of the test session for 
locomotor activity, analyzed above. Though rats previously administered repeated 
amphetamine had scores in a slightly higher range than rats administered repeated 
saline, there were no individual bins where Sidak post-hoc comparisons found 
significant diferences. 
 Stereotypy scores for both repeated drug administration groups after 1 mg/kg 
amphetamine acute injection range from 3-6. Rats previously administered repeated 
amphetamine occasionaly reached stereotypy scores of 7, but never reached scores of 8 
or 9. A two-way ANOVA (repeated administration x streotypy-bin) revealed no 
significant interaction, nor a change in recorded stereotypy scores from beginning to 




administration [F(1,6) = 0.494, p = 0.022], that was sustained across the session. 
However, Sidak post-hoc analysis comparing rats between repeated drug administration 
groups revealed rats have similar stereotypy scores if compared for individual bins. The 
stereotypy scores recorded reflect the binned locomotor activity analyzed above, where 
at the same time locomotor activity was at its highest, the stereotypy scores were 
reaching their highest, 7, in rats previously administered repeated amphetamine in the 
first 30 minutes of the test session. Regardless, injection with 1 mg/kg acute 
amphetamine after previous amphetamine sensitization does not result in stereotypic 
behavior that interferes with locomotor activity. 
 However, after acute injection with 2 mg/kg amphetamine, rats previously 
administered repeated amphetamine reach occasional scores of 8, indicating 
interference with recorded locomotor activity (Figure 1E, panel 3). A two-way 
ANOVA (repeated administration x stereotypy-bin) revealed no significant interaction, 
but found main efects of repeated administration [F(1,4) = 19.08, p = 0.012], as wel as 
a shift in stereotypy scores recorded from the beginning to end of the test session 
[F(17,68) = 2.237, p = 0.010]. For the first time, we see significant Sidak post-hoc 
comparisons between repeated drug administration groups, particularly at the end of the 
session (bin14, p = 0.004; bin 16, p = 0.004; bin 18, p < 0.001). Reflected in the high 
locomotor activity analyzed above for rats repeatedly administered saline, acute 
injection with 2 mg/kg amphetamine does not require prior amphetamine exposure to 
induce hyper-locomotor activity, as rats in this group had occasional stereotypy scores 





1.5.  Summary of amphetamine sensitization protocol efectiveness 
 In total, these data conclusively show that for our experiments, 1 mg/kg is best 
for eliciting sensitized locomotor activity in rats previously administered repeated 
amphetamine. Unlike rats acutely injected with 2 mg/kg amphetamine, after acute 
injection with 1 mg/kg amphetamine, we did not find pharmacological efects of 
amphetamine influencing locomotor activity in saline administered rats, nor did we 
observe restrictive stereotypy in the amphetamine administered rats. At this acute dose, 
we also revealed a prime window in the first 30 minutes to measure peak diferences in 
locomotor activity between repeated administration groups. This left us with a peak 
window to measure Fos expression that may be encoding locomotor sensitization. 
 
Figure 1. (on folowing page) 
A)  Schematic of repeated drug administration and acute injection protocol to elicit 
locomotor sensitization in rats. B) Locomotor activity recorded across 5 x 2-hour 
sessions of repeated administration of saline (white circles) or amphetamine (2 mg/kg; 
black cirlces). C) Locomotor activity recorded in a 90-minute test when rats previously 
administered saline (white bars) or amphetamine (black bars) were acutely injected 
with 0, 1, or 2 mg/kg amphetamine immediately before session. D) Locomotor activity 
recorded of rats previously administered repeated saline (white) or amphetamine 
(black) on test day analyzed in 5-minute bins for 3 doses of acute amphetamine 
injection. E) Stereotypic activity scored in 5-minute bins across test session for a 






























































































































































































































































































































































































































































































2.  Experiment 2: Nucleus accumbens Fos expression after locomotor sensitization 
 The goal of this experiment was to determine if there are changes in Fos 
expression in the nucleus accumbens that may encode of locomotor sensitization to 
amphetamine.  
2.1.  Locomotor activity 
 Rats sacrificed for Fos immunohistochemistry exhibited an expected sensitization 
in locomotor activity when repeatedly administered amphetamine and chalenged 1-
week later with an acute injection of 1 mg/kg amphetamine (Figure 2A). A two-way 
ANOVA (repeated administration x acute injection) showed no significant interaction, 
but revealed significant main efects of repeated administration [F(1,35) = 6.657, p = 
0.014] and acute injection [F(1,35) = 54.16, p < 0.001]. Bonferoni post-hoc comparisons 
showed significant increases in locomotor activity of rats repeatedly administered 
amphetamine and acutely injected with 1 mg/kg amphetamine when compared to rats 
administered repeated saline (p = 0.029) or acute 0 mg/kg amphetamine injection (p < 
0.001).  
2.2.  Fos expression in the nucleus accumbens 
 To measure Fos expression in the nucleus accumbens as a single structure, we 
combined quantifications for the core and shel and found changes in overal Fos 
expression (data shown by sub-area only, Figure 2B). We found rats exhibiting 
sensitized locomotor activity after repeated amphetamine and acute injection with 1 
mg/kg amphetamine also had the most Fos expression in the nucleus accumbens. A 
two-way MANOVA (repeated administration x acute injection) showed no significant 




5.528b, p = 0.008, Wilks’ λ = 0.755] and acute injection [F(2,34) = 6.299
b, p = 0.005, 
Wilks’ λ = 0.73]. This increase in Fos expression form a Fos-expressing neuronal 
ensemble, and may reflect activity of nucleus accumbens neurons encoding locomotor 
sensitization. 
 A subset of these rats exhibiting sensitized locomotor activity and expressing 
increased Fos in the accumbens were labeled for Fos/NeuN dual-fluorescence (Figure 
2E). Results showed that Fos positive neurons (mean ± SEM: 41.7 ± 10.9) and NeuN 
positive neurons (720.6 ± 10.6) are colabeled in the nucleus accumbens ~5.8% of the 
time, indicating our Fos-expressing neuronal ensemble is a very smal population of 
highly activated neurons. 
 Fos expression in accumbens shel trended in a similar direction to the Fos 
expression in the combined nucleus accumbens. We found rats exhibiting sensitized 
locomotor activity after repeated amphetamine and acute injection with 1 mg/kg 
amphetamine also had the most Fos expression in the accumbens shel (Figure 2C, 
panel 1). A two-way ANOVA (repeated administration x acute injection) analyzing Fos 
expression in the accumbens shel revealed significant main efects of repeated 
administration [F(1,35) = 10.288, p = 0.003] and acute injection [F(1,35) = 7.505, p = 
0.01], with no significant interaction. LSD adjusted simple main efects of repeated 
administration showed there were no Fos expression differences between repeated drug 
administration groups when injected with 0 mg/kg acute amphetamine, but Fos was 
significantly increased in amphetamine administered rats with 1 mg/kg acute 
amphetamine (p = 0.005). Further LSD adjusted simple main efects for acute injection 




saline, p < 0.001). These data, in addition to results from a Pearson’s corelation 
between locomotor activity and Fos expression in the shel (r = 0.354, p = 0.027) 
indicate a corelation between increased locomotor sensitization and increased Fos 
expression in the accumbens shell. 
 Though not always the case, here, we find Fos expression in the accumbens core 
changes in a similar direction to Fos expression in the shel, and thusly Fos expression 
in the combined accumbens. We found rats exhibiting sensitized locomotor activity 
after repeated amphetamine and acute injection with 1 mg/kg amphetamine also had the 
most Fos expression in the accumbens core (Figure 2C, panel 2). A two-way ANOVA 
(repeated administration x acute injection) yielded a significant interaction between 
treatment groups [F(1,35) = 4.51, p = 0.041]. Bonferoni post-hoc tests revealed a 
significant increase in Fos expression if rats had previous repeated amphetamine 
administration before acute injection with 1 mg/kg instead of 0 mg/kg amphetamine (p 
< 0.001) with no diferences between acute injection if they were previously 
administered repeated saline. However, post-hoc analysis revealed no diference 
repeated drug administration groups for either acute injection group. Similar to the 
accumbens shel, we find a corelation between locomotor activity and Fos expression 
in the accumbens core (r = 0.346, p = 0.029). 
 Though Fos expression moves in the same direction for accumbens shel and core, 
on average there are many more activated neurons in the accumbens core (407.8 ± 5.5) 
than the accumbens shel (188.7 ± 2.1), which may imply activity in response to 
diferent information. Additionaly, for a subset of rats, we also quantified slightly more 




2D). For both shel and core, we found similar efects highlighting the increased Fos 
expression of rats exhibiting increased locomotor activity (shel: significant interaction 
[F(1,16) = 9.606, p = 0.007]; core: significant main efects of repeated administration 
[F(1,34) = 5.155, p = 0.030] and acute injection [F(1,34) = 8.991, p = 0.005]).  
2.3.  Summary of Fos expression in the nucleus accumbens after locomotor 
sensitization 
 Therefore, we conclude that rats exhibiting locomotor sensitization to 1 mg/kg 
acute amphetamine injection after previous, repeated amphetamine administration have 
a Fos-expressing neuronal ensemble that appears to be represented in the nucleus 



















A) Locomotor activity on test day of rats sacrificed for Fos immunohistochemistry. B) 
Representative images of Fos-labeling in the nucleus accumbens shel and core. C) 
Quantifications of Fos-expressing neurons in nucleus accumbens shel and core after 
locomotor activity testing. D) Fos expression in more posterior areas of nucleus 
accumbens after locomotor activity testing. E) Representative images of Fos/NeuN 






























































































































































































3.  Experiment 3: Dopamine-receptor subtypes recruited to the Fos-expressing 
ensemble 
 We have established a Fos-expressing neuronal ensemble in the nucleus 
accumbens corelated to locomotor activity of rats exhibiting locomotor sensitization. 
By using RNAscope in situ hybridization, we observed diferences in the distribution of 
dopamine-receptor-expressing neurons among Fos-expressing neurons. Dopamine-
receptor-expressing neurons were colabeled with Fos for the D1-receptor or D2-
receptor (Figure 3A), or they were found to be non-dopaminergic and express Fos only. 
We aimed to determine what subtypes of dopamine-receptor-expressing nucleus 
accumbens neurons were recruited to the Fos-expressing neuronal ensemble. 
 To conserve resources, we prioritized the comparison of repeated administration 
groups. We compared locomotor activity of rats repeatedly administered amphetamine 
to rats repeatedly administered saline, and both repeated administration groups were 
acutely injected with 1 mg/kg amphetamine (results not shown). As expected, we found 
a significant increase in locomotor activity after 1 mg/kg acute amphetamine injection 
when rats were previously administered repeated amphetamine, as compared to rats 
administered repeated saline (t = 2.716, df = 8, p = 0.026).  
3.1.  Fos-labeling with RNAscope in situ hybridization 
 Since our previous Fos expression analysis yielded slightly diferent results 
between accumbens shel and core above, we first look for a potential interaction of 
accumbens sub-areas within-subject for Fos expression by RNAscope in situ 




 We found increases in Fos expression for rats previously administered repeated 
amphetamine compared to rats administered saline when they were acutely injected 
with 1 mg/kg amphetamine on a 30-minute test session (Figure B, black asterisk). A 
two-way repeated measure ANOVA (repeated administration x accumbens sub-area) 
comparing Fos expression did not reveal a significant interaction, nor did it show a 
main efect of brain area. As expected, however, there was a significant main efect of 
repeated drug administration [F(1,8) = 7.533, p = 0.025], which revealed a significant 
increase in Fos expression for rats repeatedly administered amphetamine. Sidak post-
hoc analysis found no pairwise efects. There was, however a significant corelation 
between locomotor activity and Fos expression in the accumbens shel (r = 0.66, p = 
0.039) but not the core (r = 0.09, p = 0.809). Unlike with Fos immunohistochemistry, 
RNAscope in situ hybridization labeling did not capture diferent levels of Fos 
induction, and means between brain areas were very smiliar. It may be that the thin 
sections (16 μm) of tissue used for RNAscope in situ hybridization or diferences in 
labeling for mRNA instead of protein account for these diferences. 
3.2.  D1-receptor- and D2-receptor-expressing neurons distribution in nucleus 
accumbens 
 Before evaluating receptor distribution in Fos-expressing neurons, we first 
confirmed that RNAscope in situ hybridization properly labeled D1-receptor and D2-
receptor neurons in the accumbens shel and core population. The literature indicates 
that these receptors rarely co-express in the nucleus accumbens, and are evenly divided 
amongst medium spiny neurons, with 5-10% of neurons expressing neither (Smith et 




expressing neurons with RNAscope in situ hybridization amplifiers that were counter-
balanced in the D1- and D2-receptor channel for fluorophore. We next compared the 
labeling of these two accumbens cel types by accumbens sub-area and found expected 
distributions of dopamine-receptors. A two-way repeated measure ANOVA (cel type x 
accumbens sub-area) revealed no significant interactions or main efects. These results 
confirmed RNAscope in situ hybridization as an appropriate labeling method to observe 
diferences in dopamine-receptor subtype distribution with Fos-expressing neurons. 
3.3.  Fos-expressing neurons preferentialy recruit D1-receptor-expressing 
neurons 
 We discovered D1-receptor expressing neurons were preferentialy recruited to 
the Fos-expressing neuronal ensembles in the accumbens shel of rats exhibiting 
locomotor sensitization (Figure 3B). A two-way repeated measure ANOVA (repeated 
administration x cel subtype) found no significant interaction, nor main efect of 
repeated administration, but did uncover a significant main efect of cel subtype in 
Fos-expressing neurons [F(2,24) = 15.53, p < 0.001]. Sidak post-hoc comparisons 
revealed a significant increase D1-receptor co-expression with Fos labeled neurons of 
the accumbens shel of rats repeatedly administered amphetamine, as compared to rats 
administered saline (p = 0.012). Al other dopamine-receptor subtypes (D2-receptor-
expressing and non-dopaminergic) did not significantly difer between repeated drug 
administration group.  
 Results from accumbens core were found to be similar to accumbens shel, with 
increased recruitment of D1-receptor-expressing neurons to the Fos-expressing 




administration x cel subtype) found no significant interaction, or main efect of 
repeated administration, but did see a significant main efect of cel subtype in Fos-
expressing neurons [F(2,24) = 21.61, p < 0.001]. Sidak post-hoc comparisons revealed a 
significant increase D1-r co-expression with Fos in rats repeatedly administered 
amphetamine, as compared to rats administered saline (p = 0.043). Al other dopamine-
receptor subtypes (D2-receptor-expressing and non-dopaminergic) did not significantly 
difer between repeated drug administration group. 
3.4.  Summary of dopamine-receptor co-expression with Fos-expressing neuronal 
ensembles 
 In summary, D1-receptor-expressing neurons were the primary neuron recruited 
to Fos-expressing neuronal ensembles of accumbens core and shel in rats exhibiting 
locomotor sensitization to amphetamine. This unique finding confirms that distribution 
of neurons recruited to become part of the Fos-expressing neuronal ensemble found in 
the nucleus accumbens after locomotor sensitization to amphetamine is not random or 

















A) Representative images of mRNA labeling with RNAscope in situ hybridization for 
D1-receptors (green), D2-receptors (red), and Fos (white). B) Graph depicting the total 
number of Fos neurons labeled by RNAscope in situ hybridization, indicated by the 
dashed line and black star, as wel as dopmaine-receptor subtype distribution within the 
Fos-expressing neruonal population showing significance only in the D1-receptor 





































































































4.  Experiment 4: ΔFosB-expressing neurons were recruited to the Fos-expressing 
ensemble 
 We aimed to further characterize the types of neurons being recruited to the 
Fos-expressing neuronal ensemble found in rats exhibiting locomotor sensitization to 
amphetamine. We measured the co-expression of Fos and ΔFosB. ΔFosB is a stable 
protein known to be upregulated with amphetamine sensitization, and here we tested if 
ΔFosB was a reliable marker of neurons activated during conditioning and then 
observed co-expression of Fos and ΔFosB in an atempt to understand the relationship 
between neurons encoding locomotor sensitization and those activated previously 
during sensitization conditioning. 
4.1.  ΔFosB as a label for neurons activated during sensitization conditioning to 
amphetamine 
 Alternate brain sections from rats that were labeled for Fos expression in 
Experiment 2 were labeled for ΔFosB immunohistochemistry. These rats showed 
reliable locomotor sensitization (Figure 4A). A two-way ANOVA (repeated 
administration x acute injection) revealed a significant interaction (repeated 
administration x acute injection) [F(1,50) = 5.023, p = 0.029] on locomotor activity 
(Figure 4a). Bonferoni post-hoc comparisons show significant increases in locomotor 
activity of repeatedly administered amphetamine and acutely injected with 1 mg/kg 
amphetamine when compared to rats administered repeated saline (p = 0.001) or acute 
0 mg/kg amphetamine injection (p < 0.001).  
 To measure ΔFosB expression in the nucleus accumbens as a single structure, we 




(data shown by sub-area only, Figure 4B). We found increases in ΔFosB expression 
coincided with previously administered repeated amphetamine with no change in 
expression as a result of acute injection. A two-way MANOVA (repeated 
administration x acute injection) showed no significant interaction, nor significant main 
efects of acute injection, but yielded significant main efects of repeated administration 
[F(2,50) = 29.548
b, p < 0.001, Wilks’ λ = 0.462]. The increased ΔFosB expression 
indicates labeling of neuron activity from the conditioning sessions, and reflected in 
known diferences between locomotor activity during conditioning between rats 
repeatedly administered amphetamine or saline. Therefore, neurons expressing ΔFosB 
form what we wil cal a ΔFosB-expressing conditioning ensemble, and can be 
measured for co-expression with Fos.  
 Further analysis of the ΔFosB expression in the accumbens shel trended similar 
to the combined nucleus accumbens. We found rats that were previously administered 
repeated amphetamine had increased ΔFosB expression regardless of acute injection or 
locomotor sensitization output (Figure 4C, panel 1). A two-way ANOVA (repeated 
administration x acute injection) analyzing ΔFosB expression in the accumbens shel 
revealed significant main efects of repeated administration [F(1,50) = 33.597, p < 0.001] 
and no efect of acute injection. LSD adjusted simple main efects of repeated 
administration showed there were significant ΔFosB expression diferences between 
repeated drug administration groups (p < 0.001). Bonferoni post-hoc comparisons 
between al rats repeated drug administration groups were significantly diferent no 




 Similar changes in ΔFosB expression were found in the accumbens core as 
were found in accumbens shel and combined accumbens. We found rats that were 
previously administered repeated amphetamine had increased ΔFosB expression 
regardless of acute injection or locomotor sensitization output (Figure 4C, panel 2). A 
two-way ANOVA (repeated administration x acute injection) analyzing ΔFosB 
expression in accumbens core revealed significant main efects of repeated 
administration [F(1,50) = 36.021, p < 0.001] and no efect of acute injection. LSD 
adjusted simple main efects of repeated administration showed there were significant 
ΔFosB-expression diferences between repeated drug administration groups (p < 
0.001). Bonferoni post-hoc comparisons between repeated drug administration groups 
were significantly diferent no mater the acute injection dose (al, p ≤ 0.03). 
 Together, these data suggest ΔFosB expression in the accumbens shel and core 
mark neurons that were activated during conditioning, and form a ΔFosB-expression 
conditioning ensemble. The ability to label neurons that are not acutely induced by 
amphetamine make this ensemble perfect for labeling neurons activated during 
conditioning of amphetamine sensitization, and can be compared to activated neurons 

















A) Locomotor activity of rats sacrificed for ΔFosB immunohistochemistry. B) 
Representative images of ΔFosB immunohistochemistry for accumbens shell and core. 
C) ΔFosB positive neurons quantified in the nucleus accumbens core and shel after 



























































































































4.2.  Fos/ΔFosB co-expression after locomotor sensitization 
  We showed that we could induce and measure neurons activated on test day by 
labeling the transient protein Fos, and that we could label neurons activated by repeated 
amphetamine administration by labeling the stable protein ΔFosB. However, to look at 
the co-expression of Fos and ΔFosB and determine recruitment of neurons activated 
during conditioning of amphetamine sensitization with neurons activated in rats 
exhibiting locomotor sensitization on test day in the same brain section, we needed to 
adjust our antibody labels of these neurons, as both antibodies that have been used for 
these experiments required an anti-rabbit secondary. Therefore, in these experiments 
we made use of the Fos-GFP transgenic rat contained a transgene that alowed for 
expression of FosGFP under a modified Fos promoter (Figure 5A). The goal was to 
substitute the Fos-labeling antibody with a FosGFP labeling antibody in order to look at 
co-expression of Fos-expressing neurons and ΔFosB-expressing neurons.  
 To confirm the substitution of FosGFP-labeling by anti-GFP antibody we 
measured co-expression of Fos and FosGFP in the accumbens of Fos-GFP transgenic 
rats. We sensitized Fos-GFP transgenic rats with our established protocol and found 
that using an anti-GFP antibody and our standard anti-Fos antibody, across al treatment 
groups colabeling of FosGFP-expressing neurons (107 ± 13.3) and Fos-expressing 
neurons (102.5 ± 13.0) yielded approximately 95% overlap (Figure 5B). Near perfect 
co-expression of Fos with FosGFP made it a suitable replacement for future 
experiments. Next, we examined co-expression of FosGFP and ΔFosB and found 
increased recruitment of ΔFosB-expressing neurons to the Fos-expressing neuronal 




 A further look at the locomotor activity of the amphetamine sensitized Fos-GFP 
transgenic rats indicated normal sensitization behavior (Figure 5D). A two-way 
ANOVA (repeated administration x acute injection) on the locomotor activity of Fos-
GFP transgenic rats revealed no interaction, but showed significant main efects of 
repeated administration [F(1,20) = 13.14, p = 0.002] and acute injection [F(1,20) = 14.585, 
p = 0.001]. As previously seen, Bonferoni post-hoc comparisons showed significant 
increases in locomotor activity of amphetamine sensitized rats acutely injected with 1 
mg/kg amphetamine when compared to rats administered repeated saline (p = 0.036) or 
acutely injected with 1 mg/kg amphetamine (p = 0.038).  
 Next, we measured FosGFP expression in the nucleus accumbens of these rats 
and found increased effects of acute 1 mg/kg amphetamine injection that did not relate 
to locomotor sensitization (Figure 5E). A two-way ANOVA (repeated administration x 
acute injection) for quantification of FosGFP labeled neurons (Figure 4e) had a 
significant main efect of acute injection [F(1,20) = 7.818, p = 0.011]. LSD adjusted 
simple main efects showed rats administered repeated amphetamine had significantly 
more FosGFP expression after 1 mg/kg rather than 0 mg/kg acute amphetamine 
injection (p = 0.026). Though expected based on the previous findings, in Fos-GFP 
transgenic rats we did not see a diference between repeated drug administration groups 
acutely injected with 1 mg/kg amphetamine, which may be an efect of the labeling 
FosGFP in place of Fos, or as has been found before, protein labeling may be diferent 
between diferent strains of rodent (Conversi et al., 2011). It is worth noting that 
average numbers of Fos-expressing cels in al immunofluorescent findings have been 




previous findings, we showed, as expected expected, labeling of ΔFosB neurons 
coincided with repeated drug administration (Figure 5F). A two-way ANOVA 
(repeated administration x acute injection) analyzing ΔFosB expression had a 
significant main efect of repeated administration [F(1,20) = 13.64, p = 0.001], and LSD 
adjusted simple main efects that revealed significant diferences between repeated 
drug administration group when acutely injected with either 0 mg/kg (p = 0.018) or 1 
mg/kg amphetamine (p = 0.016).  
 Finaly, we looked for co-expression of FosGFP and ΔFosB in Fos-GFP 
transgenic rats that underwent amphetamine sensitization and found increased 
recruitment of ΔFosB-expressing neurons to the Fos-expressing neuronal ensemble of 
rats exhibiting locomotor sensitization (Figure 4G). A two-way ANOVA (repeated 
administration x acute injection) showed significant main efects of both repeated 
administration [F(1,20) = 5.985, p = 0.024] and acute injection [F(1,20) = 13.54, p = 
0.002], with no significant interaction. Bonferoni post-hoc comparisons revealed more 
FosGFP/ΔFosB colabeled neurons in rats repeatedly administered amphetamine and 
acutely injected with 1 mg/kg amphetamine when compared to rats repeatedly 
administered saline (p = 0.029) or acutely injected with 0 mg/kg amphetamine (p = 
0.006). This revealed that neurons activated during repeated amphetamine 
administration were more likely to also be activated during locomotor sensitization, 









A) Schematic of Fos-GFP transgenic rat. B) Representative images of FosGFP and Fos 
expression and co-expression with immunofluorescence. C) Representative images and 
diagram of FosGFP/ΔFosB co-expression with immunofluorescence (DFB = ΔFosB). 
D) Locomotor activity of Fos-GFP transgenic rats sacrificed for FosGFP/ΔFosB 
colabeling. E) Fos immunofluorescence, F) ΔFosB immunofluorescence, and G) Co-



























































































































































































































































































































































































































5.  Experiment 5: Learned associations influenced locomotor sensitization and 
Fos-expression 
5.1.  Learned associations of context-specific locomotor sensitization  
 In order to determine if locomotor sensitization we observed in rats repeatedly 
administered amphetamine and acutely injected with 1 mg/kg amphetamine on test day 
was a result of learned associations to context, we developed controls for our 
amphetamine sensitization protocol to test for context-specific locomotor sensitization. 
We conditioned rats with repeated drug administration in a novel context (context B) 
that was distinct from the testing locomotor chambers (context A) (Figure 6A). Prior to 
sensitization conditioning in either context, rats were habituated for 2-hours in context 
A to reduce excessive novelty exploration on test day. Locomotor activity recorded 
during these habituation sessions prior to repeated drug administration was similarly 
low for al rats (150.64 ± 0.81 meters). 
 Ultimately, tests revealed locomotor sensitization was consistent with what we 
have previously found when rats were conditioned and tested in the same context, but 
additionaly found that conditioning in an alternate context prevented locomotor 
sensitization. A three-way ANOVA (conditioning context x repeated administration x 
acute injection) of locomotor activity on test day was not significant. Because we 
wanted to compare locomotor sensitization by context, we next ran a two-way 
ANOVAs (repeated administration x acute injection) to compare locomotor activity for 
each separate conditioning context (Figure 6B). For context A conditioned rats, we 
found a significant interaction [F(1,51) = 8.762, p = 0.047] between repeated 




administration [F(1,51) = 21.18, p < 0.001] and acute injection [F(1,51) = 134.7, p < 
0.001]. As seen previously for context A conditioned rats, Bonferoni post-hoc tests 
showed significant increases in locomotor activity of amphetamine sensitized rats 
acutely injected with 1 mg/kg amphetamine when compared to rats administered 
repeated saline (p < 0.001) or acute injection with 0 mg/kg amphetamine (p < 0.001). 
For context B conditioned rats, we found no significant interaction, nor main efect of 
repeated administration, but did find a significant main efect of acute injection [F(1,40) 
= 55.67, p < 0.001]. LSD simple main efects showed that rats acutely injected with 0 
mg/kg or 1 mg/kg amphetamine had significant diferences when previously 
administered repeated amphetamine (p < 0.001) or saline (p < 0.001). Further, 
Bonferoni post-hoc analysis confirmed there was no significance between repeated 
drug administration groups after acute injection with 1 mg/kg amphetamine, meaning 
there was no significant locomotor sensitization in rats conditioned in a diferent 
context from which they were tested. 
5.2.  Fos expression after context-specific locomotor sensitization 
 We next considered how the Fos-expressing neurons reflected the diferences rats 
exhibitied in locomotor sensitization when they were conditioned with repeated 
amphetamine administration in a diferent context from which they were tested for 
sensitization. Because histological results of the nucleus accumbens were best 
represented by efects seen in the accumbens shel, we chose to limit analysis to 
accumbens shel for all future experiments. 
 We found rats conditioned in context A had increased Fos expression in the 




way ANOVA (repeated administration x acute injection) revealed a significant 
interaction [F(1,51) = 5.448, p = 0.024] as wel as significant main efects for repeated 
administration [F(1,51) = 10.53, p = 0.002] and acute injection [F(1,51) = 7.873, p = 
0.007]. Consistent with our previous findings from rats conditioned and tested in the 
same context, Bonferoni post-hoc tests confirmed Fos expression was significantly 
increased in amphetamine sensitized rats acutely injected with 1 mg/kg amphetamine 
when compared to rats administered repeated saline (p = 0.001) or acutely injected with 
0 mg/kg amphetamine (p = 0.004). We further confirmed a corelation between 
locomotor activity and Fos expression in the accumbens shel (r = 0.449, p < 0.001) for 
rats conditioned in the same context in which they are tested. 
 We found rats conditioned in context B did not have Fos expression increases in 
accumbens shel after repeated amphetamine administration and acute injection with 1 
mg/kg amphetamine (Figure 6C, panel 2). A two-way ANOVA (repeated 
administration x acute injection) found no significant interaction, or main efect of 
acute injection, which indicated that rats conditioned in context B expressed the same 
amount of Fos expressed in accumbens shel when tested with 0 mg/kg or 1 mg/kg 
amphetamine in a diferent context from which they were conditioned. We did, 
however, find a significant main efect of repeated administration [F(1,61) = 4.233, p = 
0.044]. Yet, LSD adjusted simple main efects showed no significant diferences 
between repeated drug administration group for either acute injection dose. We found 
no corelation between the locomotor activity on test day and Fos expression (r = 0.626, 




 Therefore, in the accumbens shel, we revealed a context-specific nature of Fos 
expression dependent on whether rats were conditioned in the same or an alternate 
context from which they were tested. We also found Fos expression only corelated to 
locomotor sensitization when rats were conditioned and tested in the same context. 
These results confirmed that earlier findings about locomotor sensitization after our 
amphetamine sensitization protocol did alow for observation of learned associations 
between context and drug efects that may be reflected in the Fos-expressing neuronal 
ensemble. 
5.3.  ΔFosB expression after context-specific locomotor sensitization 
 Lastly, to confirm that learning in context B for the diferent repeated drug 
administration groups was similar to learning in context A, we analyzed ΔFosB 
expression in the accumbens shel by conditioning context. As previously seen, we 
found increased ΔFosB expression when rats were previously administered repeated 
amphetamine (Figure 6D, panel 1). A two-way ANOVA (repeated amphetamine x 
acute injection) analyzing ΔFosB expression in the accumbens shel of rats conditioned 
in context A revealed a main efect of repeated administration [F(1,51) = 38.65, p < 
0.001]. LSD adjusted simple main efects showed rats administered repeated 
amphetamine had significantly increased ΔFosB expression compared to rats 
repeatedly administered saline whether acutely injected with 0 mg/kg (p < 0.001) or 1 
mg/kg amphetamine (p < 0.001). Bonferoni adjusted post-hoc tests also revealed that 
there was no diference between rats acutely injected with 0 mg/kg or 1 mg/kg 
amphetamine after repeatedly administered amphetamine, indicating that sensitization 




learned associations between context and drug efects. ΔFosB expression changed in 
exactly the same way for rats conditioned in context B (Figure 6D, panel 2). A two-way 
ANOVA (repeated administration x acute injection) analyzing ΔFosB expression in the 
accumbens shel of rats conditioned in context B revealed a main efect of repeated 
administration [F(1,40) = 38.65, p < 0.001]. LSD adjusted simple main efects showed 
rats administered repeated amphetamine had significantly increased ΔFosB expression 
compared to rats repeatedly administered saline whether acutely injected with 0 mg/kg 
(p = 0.001) or 1 mg/kg amphetamine (p < 0.001). Bonferoni adjusted post-hoc tests 
also revealed that there was no diference between rats acutely injected with 0 mg/kg or 
1 mg/kg amphetamine after repeatedly administered amphetamine. Therefore, 
conditioning context did not mater for ΔFosB expression to increase. Instead, only 
repeated drug administered efected ΔFosB expression. We can infer that similar 
activity during conditioning meant that rats conditioned in either context were making 
associations between their environment and the drug rewards, but those associations 
were only useful to exhibit locomotor sensitization when rats were tested in the same 
context in which the associations were formed.  
6.  Experiment 6: Fos/ΔFosB increased co-expression after context-specific 
locomotor sensitization 
 Lastly, we wanted to determine how recruitment of the ΔFosB-expressing 
conditioning ensemble is recruited for context-specific learning. We conditioned Fos-
GFP transgenic rats with repeated amphetamine administration in context A, context B, 




 First, we measured locomotor activity, and found, as expected, rats conditioned 
and tested in the same context exhibited sensitized locomotor activity (Figure 6E, black 
bars). A one-way ANOVA (context) was significant [F(2,14) = 4.391, p = 0.033]. LSD 
adjusted comparisons showed rats had increased locomotor activity when tested in the 
same context A, as compared to rats conditioned in context B (p = 0.016), and home 
cage (p = 0.054), but that rats sensitized to amphetamine in context B had the same 
locomotor activity as rats sensitized to amphetamine in the home cage. 
 Next, we labeled for immunofluorescence of FosGFP and ΔFosB to ultimately 
determine how co-expression of these neurons is afected by contextual learning. As 
found previously with our Fos-GFP transgenic rats, labeled for FosGFP, there was no 
significant increase in FosGFP expression found between the 3 contexts, despite 
diferences in locomtor activity, shown by one-way ANOVA (Figure 6E, green and 
yelow bars combined). It is stil unclear whether this peculiar result is a result of 
labeling procedures, strain of rat, or some other factor. We did, however, successfuly 
find increased ΔFosB expression that matches previous labeling. Rats conditioned in 
either of the novel contexts had increased ΔFosB expression, while home cage 
conditioned rats had lower ΔFosB expression (Figure 6E, red and yelow bars 
combined). A one-way ANOVA (context) revealed a significant effect of context on 
ΔFosB labeling between across groups [F(2,14) = 8.714, p = 0.003]. LSD adjusted 
comparisons for rats conditioned in context A or context B were insignificant, as 
expected; however, rats sensitized to amphetamine in the home cage had significantly 
less ΔFosB expression than rats conditioned in context A (p = 0.001) and context B (p 




is a unique finding that may support the idea that ΔFosB is labeling neurons activated 
during conditioning to encode learned associations between conditioning context and 
amphetamine. 
 Finaly, colabeling of FosGFP and ΔFosB in the accumbens shel after 
locomotor sensitization across contexts was significantly increased in rats exhibiting 
locomotor sensitization, as revealed by one-way ANOVA (context) [F(2,14) = 5.974, p = 
0.013] (Figure 6E, yelow bars). LSD adjusted comparisons revealed rats that showed 
locomotor sensitization after they were conditioned and tested in context A, and also 
showed significantly increased co-expression of FosGFP and ΔFosB as compared to 
rats conditioned in context B (p = 0.031) or the home cage (p = 0.006), while rats 
conditioned in context B had no diferences in co-expression when compared to rats 
conditioned in the home cage. These unique results indicated ΔFosB-expressing 
conditioning ensembles are recruited to the Fos-expressing neuronal ensemble in a 
context-specific manner, that may be dependent on learned associations that are used to 














A) Schematic of context-specific locomotor sensitization protocol. B) Locomotor 
activity expressed after amphetamine sensitization in context A or conext B sacrificed 
for immunohistochemistry. C) Fos immunohistochemistry or D) ΔFosB of rats tested 
for context-specific locomotor activity. E) Locomotor activity (back bars) and 
immunofluorescence labeling of FosGFP (green and yelow), ΔFosB (red and yelow), 
and co-expression of FosGFP/ΔFosB (yelow) in rats sensitized to amphetamine in 
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7.  Experiment 7: Fos-expressing neuronal ensembles played a role in context-
specific locomotor sensitization  
 Here, we utilized the Daun02 inactivation procedure to ablate neurons which 
were Fos-expressing after context-specific amphetamine sensitization. This experiment 
alowed us to test for a causal role of the increased Fos-expressing neurons found after 
amphetamine locomotor sensitization. We limited experiments only to rats acutely 
injected with 1 mg/kg amphetamine on test day, and compared how Daun02 or vehicle 
microinjections into the nucleus accumbens shel of Fos-LacZ rats diferentialy efects 
locomotor activity when rats were repeatedly administered amphetamine or saline in 
context A or context B (Figure 7A). 
 To induce Fos expression for Daun02 inactivation, we injected al rats with 1 
mg/kg amphetamine and measured locomotor activity in context A on induction day. 
Rats repeatedly administered amphetamine in context A showed sensitized locomotor 
activity on induction day, while rats conditioned in context B did not (Figure 7B). A 
two-way ANOVA (conditioning context x repeated administration) showed no 
significant interaction, or efect of context, but did show a significant main efect of 
repeated administration [F(1,48) = 6.45, p = 0.014]. LSD adjusted simple main efects 
between administration drug groups revealed significantly sensitized locomotor activity 
when conditioned in context A (p = 0.010) and no diference between repeated drug 
administration groups when conditioned in context B. This aligned with previous 
findings for context-specific locomotor sensitization, and indicated that learned 
associations to the conditioning context and drug efects are influencing locomotor 




 Immediately folowing the induction day session, Fos-LacZ transgenic rats were 
microinjected with Daun02 or vehicle in the accumbens shel. A few days later we 
tested al rats with a 1 mg/kg acute amphetamine injection and recorded locomotor 
activity for changes after Daun02 inactivation. Ultimately, we found rats repeatedly 
administered amphetamine in context A decreased locomotor activity after Daun02 
microinjection, while rats conditioned in context B showed opposite efects (Figure 
7C). A three-way ANOVA (conditioning context x repeated administration x 
microinjection) yielded no significant interaction. To best determine the efect Daun02 
was having on learned associations driving context-specific locomotor sensitization, we 
next ran a two-way ANOVA (conditioning context x microinjection) spliting analysis 
by repeated drug administration group (note: graphs were split by context, while 
analysis was split by repeated administration group). We found a significant interaction 
for rats repeatedly administered amphetamine [F(1,29) = 4.948, p = 0.034], with no 
significant main efects or significant Bonferoni post-hoc comparisons. For rats 
repeatedly administered saline, there was no two-way interaction between conditioning 
context and microinjection; however, there was a main efect of context on test day 
locomotor activity [F(1,15) = 8.604, p = 0.010]. LSD adjusted simple main efects show 
Daun02 microinjections had a significant efect decreasing locomotor activity in rats 
conditioned with saline in context A (p = 0.016), but not context B (p = 0.651). It is 
unclear why saline conditioned rats injected with Daun02 would decrease locomotor 
activity on subsequent testing and may be a product of smal test groups. 
 Analysis of β-galactosidase labeling with X-gal was done for each group to 




found al groups injected with Daun02 had generaly decreased levels of β-
galactosidase expression regardless of context (Figure 7D). A two-way ANOVA 
(conditioning context x microinjection) spliting analysis by repeated drug 
administration group, revealed no significant interactions, but did yield significant main 
efects of microinjection for rats repeatedly administered either amphetamine [F(1,29) = 
19.7, p < 0.001] or saline [F(1,15) = 5.457, p = 0.034], regardless of context. However, 
LSD adjusted main efects found between vehicle and Daun02 microinjections were 
significant for amphetamine rats conditioned in context A (p < 0.001) (Figure 7E), but 
not context B, and there were no significant main efects of context for rats repeatedly 
administered saline. This tels us that although decrease in β-galactosidase staining was 
seen in al conditioning and repeated administration groups injected with Daun02, there 
was a more significant loss of Fos-expressing, β-galactosidase positive neurons in rats 
that showed context-specific locomotor sensitization on Fos-induction day than other 
groups.  
 To take it one step further, we compared within-subject contributions of the Fos-
expressing neuronal ensemble that was ablated on Fos-induction day by comparing 
locomotor activity recorded pre- (Fos-induction day) and post- (test day) microinjection 
(Figure 7F). A multifactorial, repeated measure ANOVA (pre/post x conditioning 
context x repeated administration x drug microinjected) yielded no significant 
interaction. However, it did reveal a significant three-way interaction of locomotor 
activity before and after microinjection (pre/post x conditioning context x 
microinjection) [F(1,44) = 5.026, p = 0.027]. Sidak post-hoc comparisons revealed 




Daun02 microinjection in rats conditioned in context A for both repeated drug 
administration groups (amphetamine, p = 0.003; saline, p = 0.017).  
 In summary, ablation of Fos-expressing neurons in the accumbens shel with 
Daun02 inactivation after repeated drug administration in context A decreased 
locomotor activity, and disrupted context-specific locomotor sensitization, while rats 
conditioned in context B had no change in locomotor activity after Daun02 
microinjections. Rats injected with Daun02 in al conditioning groups had a decreased 
β-galactosidase expression and therefore fewer activated neurons on test day. However, 
the loss of these neurons was only functionaly relevant in rats conditioned in context 
A. This shows a causal role of Fos-expressing neurons in the accumbens shel of 






Figure 7. (on folowing page) 
A) Schematic of Daun02 induction for amphetamine sensitization. B) Locomotor 
activity on induction day. C) Locomotor activity and D) X-gal staining on test day, after 
microinjection to the accumbens shel with Daun02 or vehicle. E) Representative 
images of nucleus accumbens after vehicle or Daun02 injection. F) Comparison of rat 















































































































































































































































































































































































































































































































































































































































































































































1.  Conclusions 
 Our findings on behavioral sensitization and related nucleus accumbens Fos 
expression were consistent with others in the literature (Robinson and Becker, 1986; 
Uslaner et al., 2001; Matson et al., 2007a). However, we were able to provide a more 
in-depth characterization of the Fos-expressing neuronal ensemble, and its role in 
learned associations of locomotor sensitization. Ultimately, these experiments 
supported our hypothesis that nucleus accumbens Fos-expressing neuronal ensembles 
encoding context-specific sensitization played a causal role in amphetamine induced 
locomotor activity. 
1.1.  Characterization of Fos-expressing neuronal ensembles encoding locomotor 
sensitization 
 Similar to previous studies (Robinson and Becker, 1986; Matson et al., 2007b), 
we confirmed low, intermitent doses of repeated amphetamine can induce sensitized 
locomotor activity in rats by showing reliable amphetamine locomotor sensitization 
after 5-days repeated amphetamine (2 mg/kg i.p.) administration, 1-week abstinence, 
and acute 1 mg/kg amphetamine injection without inducing restrictive stereotypies. 
Additionaly, increased Fos expression and ΔFosB expression in the nucleus 
accumbens shel and core supported previous findings about locomotor sensitization 
and immediate early gene expression (Chen et al., 1997; Uslaner et al., 2001). 
 While Fos expression in the nucleus accumbens was typicaly increased after 
locomotor sensitization, ΔFosB changes were not related to behavioral sensitization 




active during sensitization conditioning. Previous studies have found similar increases 
in ΔFosB expression after a variety of sensitizing conditions (Chen et al., 1997; Beloate 
et al., 2016a; Carneiro de Oliveira et al., 2016) with similar dissociation between 
ΔFosB expression and behavioral sensitization exhibited test day (Beloate et al., 
2016b). Additionaly, for the first time, we observed the overlap of the Fos-expressing 
neuronal ensemble and ΔFosB-expressing conditioning ensemble, and found that 
locomotor sensitization to acute amphetamine injection utilizes more neurons activated 
during repeated amphetamine administration. 
 We also added to a conflicting literature about the activation of the accumbens 
shel and core neurons in addiction-related behaviors, and the involvement of 
dopamine-receptor subtypes in locomotor sensitization to amphetamine. We found a 
strong relationship between increased Fos expression of the accumbens shel and 
locomotor sensitization in rats, and were able to show the accumbens core and shel 
have similar, proportional activity-dependent changes to Fos and ΔFosB expression 
after our amphetamine sensitization protocol. Furthermore, RNAscope labeling 
revealed D1-receptor-expressing neurons were preferentialy recruited to nucleus 
accumbens Fos-expressing ensembles encoding locomotor sensitization, which may 
help encode sensitization behavior (Kai et al., 2015). 
1.2.  Evaluation of the role of Fos-expressing neuronal ensembles play in context-
specific locomotor sensitization 
 Context-specific behavioral sensitization studies, with similar characteristics to 
our protocol for locomotor sensitization, have been done before for a range of 




amphetamine that relied on learned-associations to environmental cues by conditioning 
rats with repeated amphetamine administration in diferent contexts. We revealed 
changes in expression of sensitized locomotor activity and Fos expression were only 
significant when rats were repeatedly administered amphetamine and acutely injected 
with amphetamine in the same contexts. In addition, we found context-specific efects 
of Fos expression in nucleus accumbens shel on test day that reflected locomotor 
sensitization. ΔFosB expression was increased after repeated amphetamine 
administration equaly for two diferent novel contexts, and less for rats conditioned 
with repeated amphetamine in the home cage, which further suggested ΔFosB 
expression was occuring as novel learned associations that encode locomotor 
sensitization are forming. We found changing the context in which rats were 
conditioned and tested reduced overlap of Fos-expressing neuronal ensembles and 
ΔFosB-expressing conditioning ensembles. 
 Findings from ablation of Fos-expressing neurons in the accumbens shel after an 
induction test and Daun02 inactivation established a causal role of the neuronal 
ensemble in locomotor sensitization. We saw efects only after deletion of Fos-
expressing neuronal ensembles in rats sensitized in a context specific manner, despite 
decreased Fos-expression, as labeled by β-galactosidase, across al rats microinjected 
with Daun02. Other studies have also shown a causal role for the smal population of 
Fos-expressing neuronal ensembles in the nucleus accumbens after cocaine behavioral 
sensitization (Koya et al., 2016) and other addiction-related behaviors relying on 




 Our findings about the causal role of Fos-expressing neuronal ensembles in 
context-specific locomotor sensitization, and the variations we found in recruitment of 
neurons encoding learned associations to context-specific locomotor sensitization add 
to a rich, trending literature about the importance of neuronal ensembles.  
2.  Future directions 
 As we have generaly identified a behavioral model to study conditioned learning, 
there are many new questions that can be answered about the Fos-expressing neuronal 
ensemble. Though not a comprehensive list, three major lines of investigation to 
consider would be (i) the comparison between globaly found neuronal alterations and 
unique alterations in Fos-expressing neurons, (i) the testing of established, relevant 
neuronal subtypes in an activity-dependent manner, and (ii) the manipulation of the 
sensitization protocol to alter encoding of learned associations in context-specific 
locomotor sensitization. Here, I wil elaborate on these directions, indicating some 
research already exploring these areas, and other interesting targets for consideration. 
 Using the context-specific amphetamine sensitization protocol, examination of 
known global neuronal alterations could be measured in the behavior encoding Fos-
expressing neuronal ensemble. Established methods to determine molecular, celular, 
and electrophysiological properties of the cel could be combined with transgenic or 
viral technologies to measure unique alterations in strongly-activated neurons. In fact, 
experiments using FACS (Liu et al., 2014; Li et al., 2015; Rubio et al., 2016), analyzing 
dendritic spine morphology (Grueter et al., 2013; Singer et al., 2016), and recording 
with slice electrophysiology (Koya et al., 2012; Whitaker et al., 2017) have identified a 




transgenic rodent models or targeted brain infection with viral vectors encoding 
designer genes behind a Fos-promoter, or another immediate early gene promoter. 
However, it is possible with non-transgenic labeling techniques to identify these 
neurons for celular changes (Liu et al., 2014; Singer et al., 2016). Additional 
interesting learned-association targets that are known to induce global neural 
adaptations after amphetamine sensitization include surface receptors (AMPA: (Wolf, 
2016; Wang et al., 2017a); NMDA: (Li et al., 2016; Voyer et al., 2017) , μ-opioid: (Kuo 
et al., 2016)), proteins modulating receptor expression (arestin: (Zurkovsky et al., 
2017); cadherin: (King et al., 2017), regulatory peptides (ghrelin: (Jang et al., 2017), 
Cdk5/p35: (Mlewski et al., 2016) and roles of long non-coding RNAs(Zhu et al., 
2015). Therefore, comparing changes in these molecular targets for Fos-expressing and 
non-Fos-expressing neurons after amphetamine locomotor sensitization could prove 
fruitful for determining mechanisms encoding conditioned learning. 
 Another interesting line of research would be testing the role of neuron subtypes 
recruited to the Fos-expressing population. Here, we showed a heterogeneous subtype 
of accumbens neurons that are both D1-, D2-, and non-dopamine-receptor expressing 
were recruited to the Fos-expressing neuronal ensemble that plays a role in learned 
associations of amphetamine sensitization. Manipulating the enhanced D1-receptor 
population that we found were recruited to encode sensitized locomotor activity may 
elucidate circuitry needed for conditioned learning. For example, rats with transgenes 
encoding the bacterial protein cre-recombinase under a D1-receptor promoter could be 
combined with a viral vector, that caries a cre-dependent gene, that would selectively 




specificaly activated neurons from other neural subtypes found in nucleus accumbens, 
such as parvalbumin expressing interneurons found to be required for amphetamine 
sensitization when globaly inhibited (Wang et al., 2017b), may introduce a critical sub-
population within the Fos-expressing neuronal ensembles driving learned behavior.  
 Also of potential interest is the ΔFosB-expressing conditioning ensemble our 
study found that labels activity during sensitization conditioning. Further exploration of 
the role ΔFosB directly plays, or the role neurons ΔFosB labels play, after locomotor 
sensitization expression merits investigation. In other studies, ΔFosB overexpression 
has been linked to differential modification of the synaptic properties of medium spiny 
neurons for D1-receptor- and D2-receptor-expressing neurons, as wel as diferent 
modifications by accumbens sub-areas (Grueter et al., 2013). Future experiments could 
test synaptic properties of Fos/ΔFosB co-expressing neurons, additionaly evaluating 
dopamine-receptor subtypes of medium spiny neurons or diferences between 
accumbens shel and core, and could possibly yield new mechanisms of learning.  
 Lastly, manipulation of the amphetamine sensitization protocol may highlight 
diferent dynamics of the Fos-expressing neuronal ensemble. One manipulation could 
be to extend the withdrawal period. Recent studies altering withdrawal periods between 
context-specific sensitization conditioning and behavioral sensitization testing found 
the longer memories are incubated, the more generalized learned associations become 
and context-specificity is lost (Engelke et al., 2017). Testing our protocol with varied 
withdrawal periods may expose a transition of neuronal ensembles to other brain areas, 
or a refinement or expansion of the Fos-expressing ensemble after incubation. The role 




begun to be tested for forced abstinence (Fanous et al., 2012) and voluntary abstinence 
(Caprioli et al., 2017). Other interesting protocol manipulations could be to house rats 
in an enriched environment before sensitization. This exposure has already shown to 
decrease novelty related amphetamine sensitization (Garcia et al., 2017), but may 
change how Fos expression in the nucleus accumbens corelates with locomotor 
sensitization behavior. Since our experiments found novelty-dependent efects of 
ΔFosB expression, as rats conditioned in the novel contexts had more ΔFosB 
expression than rats conditioned in the home cage, it would be particularly interesting 
to see how Fos/ΔFosB co-expression changes after context-specific amphetamine 
locomotor sensitization when rats are housed in enriched environments. 
 As with many experiments, our results created more questions than we can 
answer here. With beter technologies and methods in place, studying neuronal 
ensembles of highly activated neurons is becoming more available, and should be 
considered for studying addiction-related learning in the future. 
3.  Summary 
 Studying a smal, activity-dependent population of neuronal ensembles has 
proven, with previous studies, to be useful in identifying unique alterations that are 
distinct from global changes in the same areas, particularly for addiction-related 
behaviors. Here, we established a causal role that Fos-expressing neuronal ensembles 
played in the nucleus accumbens to encode context-specific locomotor sensitization to 
amphetamine. We characterized distinct diferences in recruitment of dopamine-
receptor expressing nucleus accumbens neurons, as wel as recruitment of previously 




investigating encoding of learned associations that drive addiction-related behavior. 
Using our model of learned associations, it is possible to test for unique alterations 
encoding highly complex learned associations, which can be used to inform 









































































Appendix A: Statistical assumptions of data 
 When comparing diferences between groups using ANOVAs, there are three 
main assumptions that must be met; data must prove (i) independence of cases, (i) 
normal distributions of the dependent variable, and (ii) equality of dependent variable 
variances. For experimental data sets where we ran an ANOVA, we assessed validity of 
these three assumptions using IBM SPSS 23 and Laerd Statistics guides (Cite Laerd). 
To satisfy each assumption, we tested for (i) data outliers, (i) normality, and (ii) 
homogeneity. Certain analyses also involved extra tests for linearity, sphericity, etc. as 
explained below. 
 Independence of cases via outliers was typicaly identified graphicaly by boxplot 
for data points 1.5 (outliers) or 3.0 box-lengths (extreme outliers) from the edge of the 
boxplot. In some instances, we used assessment of studentized residuals (quotient 
resulting from division of a residual by the estimation of its standard deviation) for 
absolute values greater than 3. Values greater than 3 were further assessed, while al 
lesser numbers were accepted in the data set. 
 To test for normality of data, we used the Shapiro-Wilk’s test and identified 
values that were greater than 0.05 as compliant with normality. Within the various 
ANOVAs, if a single group (defined by the colection of factors for the ANOVA being 
tested) did not meet this criteria for normality, assessment of the Normal Q-Q plot was 
performed to examine general linearity of the data. For Normal Q-Q plots deemed non-
linear, we reassessed and accepted Shapiro-Wilk’s test values greater than 0.05 divided 




 To test for homogeneity of variance, we used a Levene’s test for equality of 
eror variance accepting data sets with values greater than 0.05. Where noted, we also 
used a Box’s M test for homogeneity of covariance matrices. We proceeded with 
analysis of data sets that violated homogeneity of repeated measure testing when the 
variance ratio between the group with the largest and smalest variance were less than 
3.  
 Under these analyses, most data sets were compliant with assumptions. Any 
occasion where assumptions were not met is noted in the results. However, for al data 
sets reported, we proceeded with the statistical analysis, despite any failed assumptions, 
based on the robustness of the ANOVAs being performed, consistency in group sizes 
within data sets, and to avoid transformations of data that would prevent other 
statistical groups from meeting test criteria.  
 For mixed model ANOVAs and repeated measure ANOVAs, we also determined 
prefered analysis metrics based on Mauchly’s test of sphericity. If the sphericity test 
was violated (p < 0.05) we examined the epsilon (ϵ) values of the data. In al cases 
where sphericity failed, we chose to accept the Greenhouse-Geiser analysis, reporting 
original df-values. 
A.1.  Experiment 1: Confirming amphetamine sensitization protocols elicit 
sensitization conditioning 
A.1.1.  Repeated drug administration efects on conditioning assessed by repeated 
measure two-way ANOVA 
There were three outliers, as assessed by inspection of a boxplot. However, there were 




residuals for values greater than 3. Data was distributed normaly (p > 0.05) with the 
exception of saline rats on sessions 4 and 5 (p = 0.002 and 0.015, respectively), as 
assessed by Shapiro-Wilk’s test. However, Normal Q-Q plots were visual assessment 
for these groups and deemed linear. There was not homogeneity of variances on any 
repeated administration session, as assessed by Levene’s test of homogeneity of 
variance (p < 0.05). Nor was there homogeneity of covariances, as assessed by Box’s 
test of equality of covariant matrices (p < 0.001). We then calculated the variance ratio 
of the group with the highest variance to the lowest variance, which was less than 3.  
Mauchly’s test of sphericity indicated that the assumption of sphericity was violated for 
the two-way interaction, χ-square = (50.265), p < 0.001). We therefore reported 
Greenhouse-Geisser analysis (ϵ = 0.600).  
A.1.2.  Repeated drug administration efects on locomotor activity with dose 
dependent testing assessed by two-way ANOVA 
 There were two outlier rats in the data set, as assessed in a boxplot. Further 
analysis of studentized data yielded no values greater than the absolute value of 3. Data 
were normaly distributed (p > 0.05), with the exception of rats repeatedly administered 
amphetamine and acutely administered 0 mg/kg (p = 0.011) and 2 mg/kg amphetamine 
(p = 0.49), as assessed by Shapiro-Wilk’s test. Normal Q-Q plots were assessed 
visualy for these groups and deemed linear. The assumption of homogeneity of 
variances was violated as assessed by Levene’s test for equality of variances (p = 
0.041). We chose to continue with analysis, despite this violation due to the robustness 




A.1.3.  Repeated drug administration efects on binned-locomotor activity with 
dose dependent testing assessed by three-way mixed model ANOVA 
There were few data outliers in individual bins, as assessed by inspection of a boxplot. 
We chose to leave these unique data points as a part of the data set to be analyzed, as no 
individual rat had an excessive number of bins in which they were outliers. The binned 
data was not normaly distributed, as assessed by Shapiro-Wilk’s test (p > 0.05); 
however, they were normaly distributed, as visualy assessed by Normal Q-Q Plot. 
There was homogeneity of variances in most bins, as assessed by Levene’s test for 
equality of variances (p > 0.05). Concern about non-homogeneity of variance in the few 
bins without homogeneity was disregarded because of approximately equal sample size 
per treatment group, and the robustness of the three-way mixed ANOVA.  
Mauchly’s test of sphericity indicated that the assumption of sphericity had been 
violated [χ-square(152) = 306.095, p < 0.001]. We therefore reported Greenhouse-
Geisser analysis (ϵ = 0.469). 
A.1.4.  Repeated drug administration efects on binned-stereotypic behavior with 
dose dependent testing assessed by three-way mixed model ANOVA 
 We confirmed data had normal Gaussian distributions by histogram, and 
proceeded with parametric testing. 
A.2.  Experiment 2: Establishing existence of a Fos-expressing neuronal ensemble 
in the nucleus accumbens 





 Residual analysis was performed to test for the assumptions of the two-way 
ANOVA. There were no outliers, as assessed by inspection of a boxplot. Data was 
normaly distributed, as assessed by Shapiro-Wilk’s test (p > 0.05), and confirmed with 
Normal Q-Q plot. The assumption of homogeneity of variances was violated, as 
assessed by Levene’s test for equality of variances (p = 0.003). We chose to cary on 
regardless due to equal group size.  
A.2.2.  Combined accumbens areas Fos expression assessed by two-way 
M(ultiway)ANOVA, and two-way ANOVAs by accumbens shel and core 
separately 
First, we assessed the data to ensure assumptions for a 2-way MANOVA were met. 
There was a linear relationship between the dependent variables (Fos expression in the 
accumbens shel and Fos expression in the accumbens core), as assessed by scaterplot. 
There was no evidence of multicolinearity, as assessed by Pearson corelation (|r| < 
0.9). There were no univariate outliers in the data, as assessed by inspection of a 
boxplot. There were no multivariate outliers in the data, as assessed by Mahalanobis 
distance (p > 0.001). Number of Fos cels counted in shel and core were normaly 
distributed, as assessed by Shapiro-Wilk’s test (p > 0.05). There was homogeneity of 
covariance matrices, as assessed by Box’s M test (p = 0.71). As these tests were valid 
for combined data, they were also valid for individual accumbens sub-regions. 
Data colected for mid-posterior shel and core were not assessed for assumptions. 
A.3.  Experiment 3: Using RNAscope to determine distribution of dopamine-




A.3.1.  Distribution of D1-receptor and D2-receptor expressing neurons between 
accumbens shel and core by two-way repeated measures ANOVA 
We found there were no outliers, as assessed by examination of studentized residuals, 
for absolute values greater than 3. Studentized residuals of cel quantifications were 
normaly distributed (p > 0.05), with the exception of quantification of D1 neurons in 
the core (p = 0.37), as assessed by Shapiro-Wilk’s test of normality. However, visual 
assessment by Normal Q-Q plot was deemed linear. The epsilon derived from 
Greenhouse-Geisser analysis indicates perfect sphericity (epsilon = 1.00) and therefore 
we assumed spherecity for interpretation of results.  
A.3.2.  Distribution of Fos positive nuclei co-expressing dopamine-receptor 
subtypes in accumbens core by two-way repeated measure ANOVA 
 There were no outliers in the data, as assessed by inspection of a boxplot. Data 
was normaly distributed for al groups (p > 0.05) with the exception of non-dopamine 
expressing neurons of the shel colabeled for Fos in rats repeatedly administered saline 
(p = 0.003), as assessed by Shapiro-Wilk’s test. Further analysis of this group by visual 
inspection of a Normal Q-Q plot was deemed linear. There was homogeneity of 
variances, as assessed by Levene’s test for equality of variances (p > 0.05) for al brain 
area cel types except D1-receptor-expressing neurons that were Fos positive in the 
shel (p = 0.046). However, the ratio between the largest and smalest variance group 
was less than 3, and thus compliant. Mauchly’s test of sphericity indicated that the 
assumption of sphericity was violated (χ-square(2) = 8.271, p = 0.016). We proceeded 




A.4.  Experiment 4: Determining a relationship between neurons activated during 
sensitization conditioning and the Fos-expressing neuronal ensembles found after 
amphetamine-induced locomotor sensitization 
A.4.1.  Locomotor activity of rats sacrificed for immunohistochemistry by two-
way ANOVA 
 Residual analysis was performed to test for the assumptions of the two-way 
ANOVA. There were no outliers of the data by inspection of a boxplot. Data from al 
groups were considered normaly distributed, as assessed by Shapiro-Wilk’s test (p > 
0.05), and confirmed with Normal Q-Q plots. The assumption of homogeneity of 
variances was violated, as assessed by Levene’s test for equality of variance (p = 
0.001). We chose to cary on regardless of this violation due to group size.  
A.4.2.  Combined accumbens area Fos expression assessed by two-way 
MANOVA, and two-way ANOVAs by accumbens shel and core separately 
First, we assessed the data to ensure assumptions for a 2-way MANOVA were met. 
There was a linear relationship between the dependent variables (repeated 
administration and acute injection), as assessed by scaterplot. There was no evidence 
of multicolinearity, as assessed by Pearson corelation (|r| < 0.9). There were no 
univariate outliers in the data, as assessed by inspection of a boxplot. There were no 
multivariate outliers in the data, as assessed by Mahalanobis distance (p > 0.001). 
Number of DFB cels counted in shel were normaly distributed, as assessed by 
Shapiro-Wilk’s test (p > 0.05). Quantification of DFB cels counted in the core were 
normaly distributed (p > 0.05), except in the repeated amphetamine group given 




distribution was found compliant after visual inspection of Normal Q-Q plots were 
deemed linear. There was homogeneity of covariance matrices, as assessed by Box’s M 
test (p = 0.521). As these tests were valid for combined data, they were also valid for 
individual accumbens sub-regions. 
A.4.6.  Co-expression of FosGFP and ΔFosB in nucleus accumbens shel after 
locomotor sensitization by three-way ANOVA 
 We analyzed the residuals of the data to test the assumptions of the two-way 
ANOVA. There were two outliers assessed by boxplot; however, further analyses of the 
absolute values for the studentized residuals of these rats were less than 3. Al data was 
normaly distributed, as assessed by Shapiro-Wilk’s test (p > 0.05). There was 
homogeneity of variances, as assessed by Levene’s test for equality of variances (p = 
0.761).  
A.5.  Experiment 5: Determining how learned associations to context influence 
locomotor sensitization and neuronal adaptations 
A.5.1.  Locomotor activity of context-specific locomotor sensitization for 
immunohistochemistry by three-way ANOVA 
 There were four outliers, as assessed by boxplot. The absolute value of 
studentized residual analysis for these rats were less than 3, with the exception of the 
single rat conditioned in context B with saline whose residual was 3.27. We chose to 
leave this rat for the remainder of the analysis due to the robustness of the ANOVA and 
similar group numbers. Al test for normality were valid (p > 0.05) as assessed by 




assessed by Levene’s test for equality of variances (p = 0.042). We chose to continue 
with analysis despite lack of homogeneity, due to the robustness of the ANOVA. 
A.5.2.  Fos expression in nucleus accumbens shel after context-specific locomotor 
sensitization by three-way ANOVA 
 There was a single outlier, as assessed by boxplot. The absolute value of the 
studentized residual for this rat was 3.05, which is greater than 3. We chose to leave 
this outlier in the data set, due to the robustness of the ANOVA and similar group 
numbers. Normality was considered valid (p > 0.05) for al groups except for rats 
injected with repeated amphetamine and 0 mg/kg acute amphetamine in either context. 
For these groups, Normal Q-Q plots were assessed as linear. For al groups 
homogeneity was found, as assessed by Levene’s test for equality of variances (p > 
0.05). 
A.5.3.  Fos expression in nucleus accumbens after context-specific locomotor 
sensitization by three-way ANOVA 
 There were five outliers, as assessec by boxplot; however, analysis of studentized 
residuals for these rats were al less than 3. Al data sets were found to have normal 
distribution (p > 0.05), as assessed by Shapiro-Wilk’s test. There was homogeneity of 
variances, as assessed by Levene’s test for equality of variances (p > 0.05). 
A.6.  Experiment 7: Proving a causal role of Fos-expressing neuronal ensembles in 
context-specific locomotor sensitization in Fos-LacZ transgenic rats 





 There were 4 outliers, as assessed by boxplot. The absolute values of 
studentized residuals of these rats were found to be less than 3, with the exception of 
one rat conditioned in context A with amphetamine and microinjected with Daun02 
whose residual was 3.13. We chose to leave this rat for the remainder of the analysis 
due to the robustness of the ANOVA. Data was normaly distributed (p > 0.05) with the 
exception of the context A, amphetamine conditioned group injected with Daun02 (p = 
0.005), as assessed by Shapiro-Wilk’s test. Normal Q-Q plot assessment of this group 
was deemed linear. There was homogeneity of variances, as assessed by Levene’s test 
for equality of variances (p = 0.732).  
A.6.2.  β-galactosidase expression after Daun02 inactivation by three-way 
ANOVA 
 There were 5 outliers, as assessed by boxplot. The absolute values of studentized 
residuals of these rats was found to be less than 3 for al groups. Expression of β-
galactosidase was normaly distributed (p > 0.05) for al groups. Normal Q-Q plot 
assessment of this group determined it acceptable for analysis. There was homogeneity 
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